<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1012246386
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2024
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Capitan
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ISOTRETINOIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule, soft
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Restricted
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        61.6
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GAP SA PHARMACEUTICAL" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GAP SA PHARMACEUTICAL
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 437]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        D10BA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Capitan&reg; </strong>contains isotretinoin &ndash; a substance related to vitamin A, and one of a group of medicines called retinoids (for treatment of acne).</p><p>&nbsp;</p><p>Capitan&reg; is used to treat severe forms of acne (such as nodular or conglobate acne, or acne that is at risk of causing permanent scarring) in adults and adolescents. You will use <strong>Capitan&reg; </strong>when your acne has not got better with anti-acne treatments, including antibiotics and skin treatments.</p><p><strong>Capitan&reg; </strong>should not be used to treat prepubertal acne and not in children aged less than 12 years of age.</p><p>&nbsp;</p><p><strong>Capitan&reg; </strong>treatment must be supervised by a dermatologist (a doctor specialised in the treatment of skin problems).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Capitan&reg;:</p><p>&bull; If you are pregnant or breast-feeding</p><p>&bull; If there is any chance you could become pregnant, you must follow the precautions under &ldquo;Pregnancy prevention programme&rdquo;, see section on &ldquo;Warnings and precautions&rdquo;.</p><p>&bull; If you are allergic to <em>isotretinoin</em>, peanut or soya or any other ingredients of this medicine (listed in section 6).</p><p>&bull; If you have liver disease</p><p>&bull; If you have very high levels of blood fats (e.g. high cholesterol or triglycerides)</p><p>&bull; If you have very high levels of vitamin A in your body (<em>hypervitaminosis A</em>)</p><p>&bull; If you are receiving treatment with tetracyclines (<em>a type of antibiotic</em>) at the same time (see &ldquo;Other medicines and <strong>Capitan&reg;</strong>&rdquo;)</p><p>&nbsp;</p><p>If any of these apply to you, go back to your doctor before taking any <strong>Capitan&reg;</strong>.</p><p>&nbsp;</p><p>Warnings and precautions</p><p>Talk to your doctor, pharmacist or nurse before taking <strong>Capitan&reg;.</strong></p><p><strong>&nbsp;</strong></p><p>&bull; If you have ever had any kind of mental health problems. This includes depression, aggressive tendencies or mood changes. It also includes thoughts about hurting yourself or ending your life. This is because your mood may be affected while taking Capitan&reg;</p><p>&nbsp;</p><p>Talk to your doctor if you experience persistent pain in your lower back or buttocks during treatment with <strong>Capitan&reg;</strong>. These symptoms may be signs of sacroiliitis, a type of inflammatory back pain. Your doctor may discontinue treatment with <strong>Capitan&reg; </strong>and</p><p>refer you to a specialist for treatment of inflammatory back pain. Further evaluation may be needed including imaging modalities such as MRI.</p><p>&nbsp;</p><p>Pregnancy prevention programme</p><p><strong>&nbsp;</strong></p><p><strong>Women who are pregnant must not take Capitan&reg;</strong></p><p><strong>&nbsp;</strong></p><p>This medicine can seriously harm an unborn baby (the medicine is said to be &lsquo;teratogenic&rsquo;) &ndash; it can cause serious abnormalities of the unborn baby&rsquo;s brain, face, ear, eye, heart and certain glands (thymus gland and parathyroid gland). It also makes a miscarriage more likely. This may happen even if <strong>Capitan&reg; </strong>is taken only for a short time during pregnancy.</p><p>&nbsp;</p><p>&bull; You must not take <strong>Capitan&reg; </strong>if you are pregnant or if you think you might be pregnant.</p><p>&bull; You must not take <strong>Capitan&reg; </strong>if you are breastfeeding. The medicine is likely to pass into your milk and may harm your baby.</p><p>&bull; You must not take <strong>Capitan&reg; </strong>if you could get pregnant during treatment.</p><p>&bull; You must not get pregnant for one month after stopping this treatment because some medicine may still be left in your body.</p><p>Women who could get pregnant are prescribed Capitan&reg; under strict rules. This is because of the risk of serious harm to the unborn baby</p><p><strong>&nbsp;</strong></p><p>These are the rules:</p><p>&bull; Your doctor must explain the risk of harm to the unborn baby - you must understand why you must not get pregnant and what you need to do to prevent getting pregnant.</p><p>&bull; You must have talked about contraception (birth control) with your doctor. The doctor will give you information on how not to get pregnant. The doctor may send you to a specialist for contraception advice.</p><p>&nbsp;</p><p>&bull; Before you start treatment, your doctor will ask you to take a pregnancy test. The test must show that you are not pregnant when starting treatment with <strong>Capitan&reg;</strong>.</p><p>&nbsp;</p><p>Women must use effective contraception before, during and after taking Capitan&reg;</p><p>&bull; You must agree to use at least one very reliable method of contraception (for example an intra uterine device or contraceptive implant) or, two effective methods that work in different ways (for example a hormonal contraceptive pill and a condom). Discuss with your doctor which methods would be suitable for you.</p><p>&bull; You must use contraception for a month before taking <strong>Capitan&reg;</strong>, during treatment and for a month afterwards.</p><p>&bull; You must use contraception even if you do not have periods or you are not sexually active (unless your doctor decides this is not necessary).</p><p>&nbsp;</p><p>Women must agree to pregnancy testing before, during and after taking Capitan&reg;</p><p><strong>&nbsp;</strong></p><p>&bull; You must agree to regular follow-up visits, ideally every month.</p><p>&bull; You must agree to have regular pregnancy tests, ideally every month during treatment and, because some medicine may still be left in your body, 1 month after stopping <strong>Capitan&reg; </strong>(unless your doctor decides this is not necessary in your case).</p><p>&bull; You must agree to extra pregnancy tests if your doctor asks you.</p><p>&bull; You must not get pregnant during treatment or for a month afterwards because some medicine may still be left in your body.</p><p>&bull; Your doctor will discuss all these points with you, using a checklist and will ask you (or a parent/guardian) to sign it. This form confirms that you have been told about the risks and that you will follow</p><p>the rules above.</p><p>&nbsp;</p><p>If you get pregnant while taking <strong>Capitan&reg;</strong>, <strong>stop taking the medicine straight away, </strong>and contact your doctor. Your doctor may send you to a specialist for advice.</p><p>Also, if you become pregnant within one month after you stop taking <strong>Capitan&reg;</strong>, you should contact your doctor. Your doctor may send you to a specialist for advice.</p><p>&nbsp;</p><p>Your doctor has written information on pregnancy prevention for the users of Capitan&reg; which should be given to you.</p><p><strong>&nbsp;</strong></p><p>A new prescription is needed for more treatment. Each prescription is only valid for 7 days.</p><p>Advice for men</p><p>The levels of oral retinoid in the semen of men taking <strong>Capitan&reg; </strong>are too low to harm their partners&rsquo; unborn baby. However, you must never share your medication with anyone.</p><p>&nbsp;</p><p><strong>Additional precautions</strong></p><p><strong>&nbsp;</strong></p><p><strong>You should never give this medicinal product to another person. Please take any unused capsules to your pharmacist at the end of treatment.</strong></p><p><strong>&nbsp;</strong></p><p><strong>You should not donate blood during treatment with this medicine and for 1 month after stopping Capitan&reg; because an unborn baby could be harmed if a pregnant patient receives your blood.</strong></p><p><strong>&nbsp;</strong></p><p><strong>Mental health problems</strong></p><p>You may not notice some changes in your mood and behaviour and so it is very important that you tell your friends and family that you are taking this medicine. They may notice these changes and help you quickly identify any problems that you need to talk to your doctor about.</p><p>&nbsp;</p><p>Advice for all patients</p><p><strong>&nbsp;</strong></p><p>&bull; <strong>Tell your doctor if you have ever had any mental illness </strong>(including depression, suicidal behaviour or psychosis), or if you take medicines for any of these conditions.</p><p>&bull; <strong>Severe Skin reactions </strong>(e.g. erythema multiforme (EM), Stevens- Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)) <strong>have been reported with the use of Capitan&reg;</strong>. The rash may progress to widespread blistering or peeling of the skin. You</p><p>should also look for ulcers in the mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes).</p><p>&bull; <strong>Rarely, Capitan&reg; may cause severe allergic reactions </strong>some of which can affect skin in the form of eczema, hives and bruises or red patches on arms and legs. If you develop an allergic reaction, stop taking <strong>Capitan&reg;</strong>, seek urgent advice from a doctor and tell him that you are taking this medicine.</p><p>&bull; <strong>Cut down on intensive exercise and physical activity. Capitan&reg; </strong>can cause muscle and joint pain particularly in children and teenagers undertaking vigorous physical activity.</p><p>&bull; <strong>Capitan&reg; has been associated with inflammatory bowel disease. </strong>Your doctor will take you off <strong>Capitan&reg; </strong>if you have severe bloody diarrhoea without any history of gastrointestinal disorders.</p><p>&bull; <strong>Capitan&reg; may cause dry eyes, intolerance to contact lenses and visual difficulties including decreased night vision. </strong>Cases of dry eyes not resolving after discontinuation of therapy have been reported. Tell your doctor if you have any of these symptoms. Your doctor may ask you to use lubricating eye ointment or tear replacement therapy. If you use contact lenses and you have developed intolerance to contact lenses, you may be advised to wear glasses during the treatment. Your doctor may refer you to a specialist for advice if you develop visual difficulties and you may be asked to stop taking <strong>Capitan&reg;</strong>.</p><p>&bull; <strong>Benign intracranial hypertension has been reported with Capitan&reg; use </strong>and in some cases where <strong>Capitan&reg; </strong>was used together with tetracyclines (a type of antibiotic). Stop taking <strong>Capitan&reg; </strong>and seek urgent advice from your doctor if you develop symptoms like headache, nausea, vomiting and visual</p><p>disturbances. Your doctor may refer you to a specialist to check for swelling of optic disk in the eye (papilloedema).</p><p>&bull; <strong>Capitan&reg; may increase liver enzyme levels. </strong>Your doctor will do blood tests before, during and after <strong>Capitan&reg; </strong>treatment to check these levels. If they stay high, your doctor may lower your dose or take you off <strong>Capitan&reg;</strong>.</p><p>&bull; <strong>Capitan&reg; commonly increases blood fats, </strong>such as cholesterol or triglycerides. Your doctor will test these levels before, during and after <strong>Capitan&reg; </strong>treatment. It is best that you do not drink alcoholic drinks or that you at least reduce the amount you usually drink while on treatment. Tell your doctor if you already have high blood fats, diabetes (high blood sugars), are overweight, or an alcoholic. You may need blood tests more often. If your blood fats stay high, your doctor may lower your dose, or take you off <strong>Capitan&reg;</strong>.</p><p>&bull; <strong>Tell your doctor if you have any kidney problems. </strong>Your doctor may start you on a lower dose of <strong>Capitan&reg; </strong>and then increase it to the maximum tolerated dose.</p><p>&bull; <strong>Capitan&reg; may increase blood sugar levels. </strong>In rare cases, people become diabetic. Your doctor may monitor blood sugar levels during treatment, particularly if you already have diabetes, are overweight, or are an alcoholic.</p><p>&bull; <strong>Your skin is likely to get dry</strong>. Use a skin moisturising ointment or cream and a lip balm during treatment. To prevent skin irritation, you should avoid using exfoliating or anti-acne products.</p><p>&bull; <strong>Avoid too much sun and do not use a sunlamp or sun-bed. </strong>Your skin may become more sensitive to sunlight. Before you go out in the sun, use a sun-protection product with a high protection factor (SPF 15 or higher).</p><p>&bull; <strong>Don&rsquo;t have any cosmetic skin treatments. Capitan&reg; </strong>may make your skin more fragile. Don&rsquo;t have any waxing (hair removal), dermabrasion or laser treatments (removing horny skin or scars) during treatment, or for at least 6 months after treatment. They could cause scarring, skin irritation, or rarely, changes in the colour of your skin.</p><p>&nbsp;</p><p>Children and adolescents</p><p>The use of <strong>Capitan&reg; </strong>in children under the age of 12 is not recommended. This is because it is not known if it is safe or effective in this age group.</p><p><strong>Capitan&reg; </strong>should not be used to treat prepubertal acne and not in children aged less than 12 years of age.</p><p>&nbsp;</p><p>Other medicines and Capitan&reg;</p><p><strong>&nbsp;</strong></p><p>Tell your doctor or pharmacist if you are taking or have recently taken any other medicines including herbal and non-prescription products.</p><p>&bull; <strong>Do not take vitamin A supplements or tetracyclines </strong>(a type of antibiotic) or use any skin treatments for acne while you are on</p><p><strong>Capitan&reg;</strong>. It is fine to use moisturisers and emollients (skin creams or preparations that prevent water loss and have a softening effect on the skin).</p><p>&bull; Avoid the use of topical keratolytic or exfoliative anti-acne agents while you are on Capitan&reg;.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility.</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.</p><p>&nbsp;</p><p>For more information on contraception, pregnancy and breast- feeding, see section 2 &ldquo;Pregnancy prevention programme&rdquo;.</p><p>&nbsp;</p><p>Driving and using machines</p><p>You may not see as well at night during your treatment. This can happen suddenly. In rare cases this has continued after the treatment has stopped. Drowsiness and dizziness have been</p><p>reported very rarely. If this happens to you, you should not drive or operate machinery.</p><p>&nbsp;</p><p>Capitan&reg; contains sorbitol and soya-bean oil</p><p><strong>&nbsp;</strong></p><p>&bull; <strong>Soya-bean oil. </strong>If you are allergic to peanut or soya, do not take this medicinal product.</p><p>&bull; <strong>Sorbitol: </strong>sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before you (or your child) take or receive this medicine.</p><p>&bull; <strong>Capitan&reg; 10 mg: </strong>this medicine contains up to 5 mg sorbitol in each soft capsule.</p><p>&bull; <strong>Capitan&reg; 20 mg: </strong>this medicine contains up to 7 mg sorbitol in each soft capsule.</p><p>&bull; <strong>Capitan&reg;10 mg: Ponceau 4R. </strong>May cause allergic reactions.</p><p>&bull; <strong>Capitan&reg; 20 mg: Sunset yellow FCF. </strong>May cause allergic reactions.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take <strong>Capitan&reg; </strong>exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p><strong>The usual starting dose </strong>is 0.5 mg per kilogram body weight per day (0.5 mg/kg/day). So if you weigh 60 kg, your dose will usually start at 30 mg a day.</p><p>Take the capsules once or twice daily.</p><p>Take on a full stomach. Swallow them whole, with a drink or a mouthful of food.</p><p>&nbsp;</p><p><strong>After a few weeks your doctor may adjust your dose. </strong>This depends on how you are getting on with your medicine. For most patients the dose will be between 0.5 and 1.0 mg/kg/day. If you think that Capitan&reg; is too strong or too weak, talk to your doctor or pharmacist.</p><p>&nbsp;</p><p><strong>If you have severe kidney problems</strong>, you will usually start on a lower dose (such as 10 mg/day) which will be increased up to the highest dose your body can tolerate. If your body can&rsquo;t tolerate the recommended dose, you may be prescribed a lower dose: that can mean you are treated for longer and your acne might be more likely to come back.</p><p>&nbsp;</p><p><strong>A course of treatment usually lasts for 16 to 24 weeks. </strong>Most patients only need one course. Your acne may continue to improve for up to 8 weeks after treatment. You won&rsquo;t usually start another course until then.</p><p>&nbsp;</p><p>Some people find their acne gets worse during the first weeks of treatment. It usually improves as treatment goes on.</p><p>&nbsp;</p><p><strong>If you take more Capitan&reg; than you should</strong></p><p>If you take too many capsules or someone else accidentally takes your medicine, contact your doctor, pharmacist or nearest hospital immediately.</p><p>&nbsp;</p><p><strong>If you forget to take Capitan&reg;</strong></p><p>If you miss a dose, take it as soon as you can. However, if it is nearly time for your next dose, skip the missed dose and carry on as before. Do not take a double dose (two doses close together).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of the side effects associated with the use of isotretinoin are related to the dose. The side effects are generally reversible after changing the dose or stopping treatment; however, some may continue after treatment has stopped. Some side effects can be serious, and you must immediately contact your doctor.</p><p>&nbsp;</p><p>Side effects requiring immediate medical attention: Skin problems</p><p><strong>Frequency not known </strong><em>(frequency cannot be estimated from available data)</em></p><p>&bull; Serious skin rashes (erythema multiforme, Stevens- Johnson syndrome, and toxic epidermal necrolysis), which are potentially life-threatening and require immediate medical attention. These appear initially as circular patches often with central blisters usually on arms and hands or legs and feet, more severe rashes may include blistering of the chest and back. Additional symptoms such as infection of the eye (conjunctivitis) or ulcers of the mouth, throat or nose may occur. Severe forms of rash may progress to widespread peeling of the skin which can be life threatening. These serious skin rashes are often preceded by headache, fever, body aches (flu-like symptoms).</p><p>&nbsp;</p><p>If you develop a serious rash or these skin symptoms, stop taking Capitan&reg; and contact your doctor immediately.</p><p><strong>&nbsp;</strong></p><p><strong>Mental problems</strong></p><p><strong>Rare effects </strong><em>(may affect up to 1 in every 1000 people)</em></p><p>&bull; Depression or related disorders. Signs of this include sad or altered mood, anxiety, feelings of emotional discomfort,</p><p>&bull; Existing depression getting worse.</p><p>&bull; Becoming violent or aggressive.</p><p><strong>Very rare effects </strong><em>(may affect up to 1 in every 10,000 people)</em></p><p>&bull; Some people have had thoughts about hurting themselves or ending their own lives (suicidal thoughts), have tried to end their own lives (attempted suicide), or have ended their lives (suicide). These people may not appear to be depressed.</p><p>&bull; Unusual behaviour.</p><p>&bull; Signs of psychosis: a loss of contact with reality, such as hearing voices or seeing things that are not there.</p><p>&nbsp;</p><p><strong>Contact your doctor straight away if you get signs of any of these mental problems. </strong>Your doctor may tell you to stop taking Capitan&reg;. That may not be enough to stop the effects: you may need more help, and your doctor can arrange this.</p><p>Allergic reactions</p><p><strong>Rare effects </strong><em>(may affect up to 1 in every 1000 people)</em></p><p>&bull; Serious <em>(anaphylactic) </em>reactions: difficulty breathing, or swallowing caused by sudden swelling of the throat, face, lips and mouth. Also, sudden swelling of the hands, feet and ankles.</p><p>&nbsp;</p><p><strong>Very rare effects </strong><em>(may affect up to 1 in every 10,000 people)</em></p><p>&bull; Sudden tight chest, shortness of breath and wheezing, particularly if you have asthma.</p><p>&nbsp;</p><p>If you have a serious reaction, get emergency medical help immediately.</p><p>If you have any allergic reaction, stop taking Capitan&reg; and contact your doctor.</p><p>&nbsp;</p><p>Bones and muscles</p><p><strong>Frequency not known </strong><em>(frequency cannot be estimated from available data)</em></p><p>&bull; Muscle weakness which can be potentially life-threatening, may be associated with trouble moving arms or legs, painful, swollen, bruised areas of the body, dark-coloured urine, reduced or no urine output, confusion or dehydration. These are signs of rhabdomyolysis, a breakdown of muscle tissue which can lead to kidney failure. This may occur if you are doing intensive physical activity while you&rsquo;re on Capitan&reg;.</p><p>&nbsp;</p><p>Liver and kidney problems</p><p><strong>Very rare effects </strong><em>(may affect up to 1 in every 10,000 people)</em></p><p>&bull; Yellow skin or eyes and feeling tired. These can be signs of hepatitis.</p><p>Stop taking Capitan&reg; straight away and contact your doctor.</p><p>&bull; Difficulty urinating (passing water), swollen and puffy eyelids, feeling excessively tired. These may be signs of kidney inflammation.</p><p>Stop taking Capitan&reg; straight away and contact your doctor.</p><p><strong>&nbsp;</strong></p><p><strong>Nervous system problems</strong></p><p><strong>Very rare effects </strong><em>(may affect up to 1 in every 10,000 people)</em></p><p>&bull; Lasting headache, along with feeling sick <em>(nausea)</em>, being sick <em>(vomiting) </em>and change in your eyesight including blurred vision. These may be signs of <em>benign intracranial hypertension, </em>especially if Capitan&reg; is taken with antibiotics called tetracycline. <strong>Stop taking Capitan&reg; straight away and contact your doctor.</strong></p><p><strong>&nbsp;</strong></p><p>Gut and stomach problems</p><p><strong>Very rare effects </strong><em>(may affect up to 1 in every 10,000 people)</em></p><p>&bull; Severe abdominal (tummy) pain, with or without severe bloody diarrhoea, feeling sick <em>(nausea) </em>and being sick <em>(vomiting)</em>. These can be signs of serious gut conditions. <strong>Stop taking Capitan&reg; straight away and contact your doctor.</strong></p><p><strong>&nbsp;</strong></p><p>Eye disorders</p><p><strong>Very rare effects </strong><em>(may affect up to 1 in every 10,000 people)</em></p><p>&bull; Blurred vision.</p><p>&nbsp;</p><p><strong>If you get blurred vision, stop taking Capitan&reg; straight away and contact your doctor. </strong>If your sight is affected in any other way tell a doctor as soon as you can.</p><p>&nbsp;</p><p>Other side effects:</p><p><strong>Very common side effects with Capitan&reg;: <em>(</em></strong><em>may affect more than 1 in 10 people)</em></p><p>&bull; Dryness of the skin, especially of the lips and face; inflamed skin, chapped and inflamed lips, rash, mild itching and slight peeling. Use a moisturising cream from the start of treatment.</p><p>&bull; Skin becomes more fragile and redder than usual, especially the face.</p><p>&bull; Back pain; muscle pain; joint pain particularly in children and teenagers.</p><p><strong>To avoid making any bone or muscle problems worse</strong>, cut down on intensive physical activity while you&rsquo;re on Capitan&reg;.</p><p>&nbsp;</p><p>&bull; Inflammation of the eye (conjunctivitis) and eyelid area; eyes feel&nbsp;</p><p>dry and irritated. Ask a pharmacist for suitable eye drops. If you get dry eyes and wear contact lenses, you may need to wear glasses instead.</p><p>&bull; Raised liver enzymes seen in blood tests.</p><p>&bull; Changed levels of fats in the blood (including HDL or triglycerides).</p><p>&bull; Bruising, bleeding or clotting more easily - if clotting cells are affected.</p><p>&bull; Anaemia &ndash; weakness, dizziness, pale skin &ndash; if red blood cells are affected.</p><p>&nbsp;</p><p><strong>Common side effects with Capitan&reg;: <em>(</em></strong><em>may affect up to 1 in 10 people)</em></p><p>&bull; Headache.</p><p>&bull; Higher levels of cholesterol in the blood.</p><p>&bull; Protein or blood in the urine.</p><p>&bull; More liable to get infections - if the white blood cells are affected.</p><p>&bull; Inside of the nose becomes dry and crusted, causing mild nosebleeds.</p><p>&bull; Sore or inflamed throat and nose.</p><p>&bull; Allergic reactions such as rash, itchiness. If you have any allergic reaction, stop taking Capitan&reg; and contact your doctor.</p><p>&nbsp;</p><p><strong>Rare side effects with Capitan&reg;: <em>(</em></strong><em>may affect up to 1 in 1,000 people)</em></p><p>&bull; Hair loss <em>(alopecia)</em>. This is usually only temporary. Your hair should return to normal after the treatment ends.</p><p>&nbsp;</p><p><strong>Very rare side effects with Capitan&reg;: <em>(</em></strong><em>may affect up to 1 in 10,000 people)</em></p><p>&bull; You may see less well at night; colour blindness and colour vision gets worse.</p><p>&bull; Sensitivity to light may increase; you may find that you need to wear sunglasses to protect your eyes from too bright sunlight.</p><p>&bull; Other sight problems including blurred vision, distorted vision, cloudy surface on the eye (<em>corneal opacity, cataracts</em>).</p><p>&bull; Excessive thirst; frequent need to urinate; blood tests show an increase in your blood sugar. These can all be signs of diabetes.</p><p>&bull; Acne can get worse in the first few weeks, but symptoms should improve with time.</p><p>&bull; Skin inflamed, swollen, and darker than usual, especially on the face.</p><p>&bull; Excess sweating or itching.</p><p>&bull; Arthritis; bone disorders (delayed growth, extra growth and changes to bone density); growing bones may stop growing.</p><p>&bull; Calcium deposits in soft tissue, sore tendons, high levels of muscle breakdown products in your blood if you exercise vigorously.</p><p>&bull; Increased sensitivity to light.</p><p>&bull; Bacterial infections at the base of the nail, changes to nails.</p><p>&bull; Swellings, discharging, pus.</p><p>&bull; Thickened scarring after surgery.</p><p>&bull; Increased body hair.</p><p>&bull; Convulsions, drowsiness, dizziness.</p><p>&bull; Lymph glands may become swollen.</p><p>&bull; Dry throat, hoarseness.</p><p>&bull; Hearing difficulties.</p><p>&bull; Generally feeling unwell.</p><p>&bull; High levels of uric acid in the blood.</p><p>&bull; Bacterial infections.</p><p>&bull; Inflammation of the blood vessels (sometimes with bruising, red patches).</p><p>&nbsp;</p><p><strong>Unknown frequency: <em>(</em></strong><em>frequency cannot be estimated from the available data)</em></p><p>&bull; Dark or cola-coloured urine</p><p>&bull; Problems getting or maintaining an erection</p><p>&bull; Lower libido</p><p>&bull; Breast swelling with or without tenderness in males</p><p>&bull; Vaginal dryness</p><p>&bull; Sacroiliitis, a type of inflammatory back pain causing pain in your buttocks or lower back</p><p>&bull; Inflammation of the urethra</p><p>&nbsp;</p><p>Reporting of side effects</p><p>If you get any side effects, talk to your doctor, nurse, or pharmacist. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep this medicine out of the sight and reach of children.</p><p>&bull; Do not use this medicine after the expiry date which is stated on the carton and label after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.</p><p>&bull; Do not use this medicine if you notice that the pack is damaged or shows signs of tampering.</p><p>&bull; Store below 30&deg;C.</p><p>&bull; Store in the original package and keep blister in the outer carton in order to protect from light.</p><p>&bull; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p><p>&bull; Return left over capsules to your pharmacist. Only keep them if your doctor tells you to.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; <strong>The active substance </strong>in <strong>Capitan&reg; </strong>is isotretinoin.</p><p>&bull; <strong>The other ingredients </strong>are all-rac-alpha-tocopheryl acetate, hydrogenated vegetable oil (type II), soya-bean oil hydrogenated, beeswax yellow, soya-bean oil refined, gelatin, glycerol, sorbitol liquid partially dehydrated, titanium dioxide (E-171), patent blue V (E-131) and ponceau red 4R (E-124) for the 10 mg capsule, sunset yellow FCF (E-110) for the 20 mg capsule and water purified.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Capitan® comes in soft capsules containing either 10 mg or 20 mg isotretinoin.

The 10mg capsules are violet, size 3, oval soft capsules. Capsule length is approximately 11.1 mm and width is approximately 6.8 mm.

The 20mg capsules are off-white to cream, size 6, oval soft capsules. Capsule length is approximately 13.8 mm and width is approximately 8.1 mm.

The 10 mg & 20mg soft capsules come in blister packs of 30 capsules.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Middle East Pharmaceutical Industries Co Ltd (Avalon Pharma)</p><p>8146 King Muhammad V, Sulimaniyah, RIYADH 12223 - 3904</p><p>P.O. Box 4180, Riyadh 11491, Kingdom of Saudi Arabia Tel.: 920010564</p><p dir="RTL">Fax:+966 (11) 4000225</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last approved in 06\2024.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي<strong> كابيتان</strong><strong>&reg;</strong> على المادة الفعالة أيزوتروتينوين، وهي مادة ترتبط بفيتامين أ، وتنتمي إلى مجموعة من الأدوية تُسمى الريتانويدات )لعلاج حب الشباب.(</p><p>&nbsp;</p><p dir="RTL">يُستخدم<strong> </strong><strong>كابيتان</strong><strong>&reg;</strong> في علاج الحالات الشديدة من حب الشباب )مثل حب الشباب العقدي، أو حب الشباب المكوّر، أو حب الشباب الذي قد يتسبب في خطر إحداث ندبات دائمة( لدى البالغين والمراهقين. وسوف تستخدم<strong> كابيتان</strong><strong>&reg;</strong> عندما لا يتحسن حب الشباب لديك بعد استخدام علاج مضاد لحب الشباب، بما في ذلك المضادات الحيوية وعلاجات البشرة.</p><p dir="RTL">يجب عدم استخدام<strong> كابيتان</strong><strong>&reg;</strong> في علاج حب الشباب في مرحلة ما قبل البلوغ، أو لدى الأطفال الذين تقل أعمارهم عن 12 عامًا.</p><p>&nbsp;</p><p dir="RTL">يجب أن يكون العلاج<strong> بكابيتان</strong><strong>&reg;</strong> تحت إشراف طبيب أمراض جلدية )طبيب متخصص في علاج مشكلات البشرة.(</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا يتم تناول كابيتان:&reg;<br />&bull; إذا كنتِ حاملًا أو تقومين بالرضاعة الطبيعية.<br />&bull; في حالة كان هناك احتمال أن تصبحي حاملًا، ويجب عليكِ اتباع الاحتياطات المذكورة في &laquo;برنامج منع الحمل&raquo;، راجعي القسم الذي يحمل عنوان &laquo;تحذيرات واحتياطات.&raquo;<br />&bull; إذا كنت تعاني من حساسية تجاه أيزوتريتينوين أو الفول السوداني أو الصويا أو أي من المكونات الأخرى لهذا الدواء )المذكورة في القسم .( <br />&bull; إذا كنت تعاني من مرض الكبد.<br />&bull; إذا كنت تعاني من ارتفاع شديد في مستوى دهون الدم )على سبيل المثال: ارتفاع نسبة الكوليسترول أو الدهون الثلاثية.(<br />&bull; إذا كنت تعاني من مستويات شديدة الارتفاع من فيتامين أ في الجسم )فرط فيتامين أ.(<br />&bull; إذا كنت تتلقى علاجًا يحتوي على التيتراسايكلن ) نوع من أنواع المضادات الحيوية( في الوقت نفسه، )انظر &laquo;الأدوية الأخرى وكابيتان.(&raquo;&reg;</p><p>إذا كان أي مما سبق ينطبق عليك، فراجع طبيبك قبل تناول كابيتان.&reg;</p><p>تحذيرات واحتياطات:<br />تحدث إلى طبيبك أو الصيدلي أو الممرضة قبل تناول كابيتان:&reg;<br />&bull; إذا كنت قد عانيت في أي وقت من الأوقات من أي نوع من المشكلات في الصحة العقلية، يتضمن ذلك الاكتئاب والميول العدوانية والتغيرات المزاجية، وكذلك يتضمن الأفكار المتعلقة بإيذاء نفسك أو إنهاء حياتك؛ ذلك لأن مزاجك قد يتأثر خلال فترة تناولك لكابيتان.&reg;</p><p>تحدث إلى طبيبك إذا شعرت بآلام مستمرة في أسفل الظهر أو الأرداف أثناء العلاج بكابيتان.&reg; فقد تكون تلك الأعراض علامة على الإصابة بالتهاب المفصل العجزي الحرقفي، وهو نوع من أنواع آلام الظهر الالتهابية. وقد يوقف طبيبك العلاج بكابيتان&reg; ويحيلك إلى أخصائي لعلاج آلام الظهر الالتهابية، وقد يحتاج الأمر للمزيد من التقييم، بما في ذلك استخدام طرائق التصوير، مثل التصوير بالرنين المغناطيسي.</p><p>برنامج منع الحمل:</p><p>ينبغي للنساء الحوامل عدم تناول كابيتان.&reg;<br />قد يسبب هذا الدواء أضرارًا خطيرة للأجنة، ويمكنه أن يسبب تشوهات خلقية خطيرة للأجنة في المخ والوجه والأذن والعين والقلب، وغُدد معينة )مثل الغدة الزعترية، والغدة جارة الدرقية.( كذلك قد يزيد هذا الدواء من احتمالية إجهاض الجنين، وقد يحدث ذلك حتى وإن تم تناول كابيتان&reg; لفترة قصيرة فقط أثناء الحمل.</p><p>&bull; يجب ألا تتناولي كابيتان&reg; إذا كنتِ حاملًا، أو إذا كنتِ تظنين أنك قد تكونين حاملًا.<br />&bull; يجب ألا تتناولي كابيتان&reg; إذا كنتِ تقومين بالرضاعة الطبيعية؛ فمن المحتمل أن يُفرز الدواء إلى حليبك، وقد يُسبب الأذى لطفلك.<br />&bull; يجب ألا تتناولي كابيتان&reg; إذا كان من المحتمل أن تصبحي حاملًا خلال فترة العلاج.<br />&bull; يجب ألا يحدث حمل خلال شهر بعد إيقاف هذا العلاج؛ لأن بعض الدواء قد يظل موجودًا في جسمك خلال تلك الفترة.</p><p>يُوصف كابيتان&reg; وفقًا لقواعد صارمة للنساء اللواتي من المحتمل أن يحملن ؛ ويرجع ذلك إلى خطر إصابة الجنين بأضرار خطيرة.</p><p>وهذه القواعد كالتالي:<br />&bull; يجب أن يشرح لك طبيبك خطر الأضرار التي قد يتعرض لها الجنين، ويجب أن تفهمي لماذا ينبغي أن لا يحدث حمل، وما الذي يجب عليك فعله لتتجنبي حدوث الحمل.<br />&bull; يجب أن تتحدثي مع طبيبك بخصوص منع الحمل )تنظيم النسل(، وسوف يزودك الطبيب بمعلومات عن كيفية تجنب حدوث الحمل، وقد يُرسلك الطبيب لأخصائي ليُقدم لك النصيحة بخصوص منع الحمل.<br />&bull; قبل أن تبدأي العلاج، سوف يطلب منك طبيبك إجراء اختبار حمل، ويجب أن يُظهر الاختبار أنك لست حاملًا قبل بدء العلاج بكابيتان.&reg;</p><p>يجب على النساء استعمال وسيلة فعالة لمنع الحمل قبل وأثناء تناول كابيتان.&reg;</p><p>&bull; يجب أن توافقي على استخدام وسيلة واحدة موثوقة جدًّا على الأقل لمنع الحمل )على سبيل المثال: جهاز اللولب الرحمي أو شريحة منع الحمل المزروعة(، أو وسيلتين فعالتين لمنع الحمل تعملان بطريقتين مختلفتين )على سبيل المثال: حبوب منع الحمل الهرمونية والواقي الذكري.( كما يجب مناقشة طبيبك حول الطرق التي تناسبك.<br />&bull; يجب عليك استخدام وسيلة منع الحمل لمدة شهر قبل تناول كابيتان&reg;، وخلال فترة العلاج، ولمدة شهر بعد انتهاء العلاج.<br />&bull; يجب عليك استخدام وسيلة منع الحمل حتى وإن كان الطمث لديك قد انقطع، أو لم تكوني نشطة جنسيًّا )ما لم يقرر طبيبك أنها ليست ضرورية.(</p><p>يجب أن توافق النساء على إجراء اختبار حمل قبل وأثناء وبعد تناول كابيتان.&reg;</p><p>&bull; يجب أن توافقي على إجراء زيارات متابعة منتظمة يوميًّا، ومن الأفضل أن تكون كل شهر.<br />&bull; يجب أن توافقي على إجراء اختبارات حمل منتظمة، ومن الأفضل أن تكون كل شهر أثناء العلاج، ولمدة شهر واحد بعد إيقاف العلاج بكابيتان&reg;؛ لأن بعض الدواء قد يظل موجودًا في جسمك خلال تلك الفترة )ما لم يقرر طبيبك أن هذا الأمر ليس ضروريًّا في حالتك.(<br />&bull; يجب أن توافقي على إجراء اختبارات حمل إضافية إذا طلب منك طبيبك ذلك.<br />&bull; يجب ألا تكوني حاملًا أثناء العلاج، ولمدة شهر بعد انتهائه؛ لأن بعض الدواء قد يظل موجودًا في جسمك خلال تلك الفترة.<br />&bull; سوف يناقش طبيبك كل تلك النقاط معك باستخدام قائمة مرجعية، وسيطلب منك )أو من أحد والديك/ وصيّك( توقيعها. تؤكد هذه الاستمارة على أنه قد تم إبلاغك عن المخاطر، وأنك ستتبعين القواعد المذكورة أعلاه.</p><p>إذا أصبحتِ حاملًا أثناء تناول كابيتان&reg;، فتوقفي عن تناول الدواء على الفور، واتصلي بطبيبك. وقد يُرسلك طبيبك إلى أخصائي لتلقي النصيحة.</p><p>كذلك، إذا أصبحتِ حاملًا خلال شهر واحد بعد توقفك عن تناول كابيتان&reg;، يجب عليك الاتصال بطبيبك. وقد يُرسلك طبيبك إلى أخصائي لتلقي النصيحة.</p><p>لدى طبيبك معلومات مكتوبة عن منع الحمل لمستخدمي كابيتان&reg;، والتي يجب إعطاؤها لك.<br />&nbsp;</p><p dir="RTL">كما يجب الحصول على وصفة طبية جديدة للمزيد من العلاج. كل وصفة طبية صالحة لمدة 7 أيام فقط.</p><p>&nbsp;</p><p>نصحية للرجال:</p><p dir="RTL">مستويات الريتينويد - الذي يتم تناوله عن طريق الفم- في السائل المنوي للرجال الذين يتناولون<strong> كابيتان</strong><strong>&reg;</strong> شديدة الانخفاض، بحيث لا تؤذي الأجنة، وعلى الرغم من ذلك، يجب ألا تتشارك علاجك أبدًا مع أي شخص.</p><p>&nbsp;</p><p dir="RTL"><strong>احتياطات</strong><strong> </strong><strong>إضافية</strong><strong>:</strong></p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>يجب ألا تعطي هذا الدواء شخص آخر</strong><strong>.</strong><strong> من فضلك أعطِ أي كبسولات غير مستخدمة</strong><strong> </strong><strong>للصيدلي</strong><strong> في نهاية العلاج</strong><strong>.</strong></p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>يجب ألا تتبرع بالدم أثناء العلاج بهذا الدواء ولمدة شهر بعد إيقاف العلاج</strong><strong> </strong><strong>بكابيتان</strong><strong>&reg;</strong><strong>؛</strong><strong> </strong><strong>لأنه</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>يسبب</strong><strong> </strong><strong>الأذى</strong><strong> </strong><strong>لأحد</strong><strong> </strong><strong>الأجنة</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>تم</strong><strong> </strong><strong>نقل</strong><strong> </strong><strong>دمك</strong><strong> </strong><strong>لمريضة</strong><strong> </strong><strong>حامل</strong><strong>.</strong></p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>مشكلات</strong><strong> </strong><strong>الصحة</strong><strong> </strong><strong>العقلية</strong><strong>:</strong></p><p dir="RTL">قد لا تلاحظ بعض التغييرات في مزاجك وسلوكك، ولذلك من الضروري جدًّا أن تُخبر أصدقاءك وأسرتك أنك تتناول هذا الدواء؛ لكي يلاحظوا تلك التغييرات ويساعدوك على أن تحدد بسرعة أي مشكلات تحتاج لأن تتحدث مع طبيبك بخصوصها.</p><p>&nbsp;</p><p>نصيحة لجميع المرضى:</p><p dir="RTL"><strong>&bull;</strong><strong> أبلغ طبيبك إذا كنت قد عانيت في أي وقت من الأوقات من مرض عقلي</strong> )يتضمن<strong> </strong>ذلك الاكتئاب والسلوك الانتحاري والذهان أو إذا كنت تتناول أدوية لأي من تلك الحالات.</p><p dir="RTL"><strong>&bull;</strong><strong> ردود فعل جلدية حادة</strong> )على سبيل المثال: الحُمامى&rdquo;احمرار الجلد&rdquo; عديدة الأشكال،<strong> </strong>ومتلازمة ستيفنز جونسون، وتقشُّر الأنسجة المُتموّتة البَشرَوِية التسممي( عند استخدام <strong>كابيتان</strong>.<strong>&reg;</strong> قد يتطور الطفح الجلدي إلى تقرحات واسعة الانتشار أو تقشُّر في الجلد.<strong> </strong>وينبغي لك كذلك أن تراقب ظهور تقرحات في الفم أو الحلق أو الأنف أو الأعضاء التناسلية والتهاب الملتحمة )احمرار وتورم العينين.(</p><p dir="RTL"><strong>نادرًا</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>يُسبب</strong><strong> </strong><strong>كابيتان</strong><strong>&reg;</strong><strong> </strong><strong>ردود</strong><strong> </strong><strong>فعل</strong><strong> </strong><strong>تحسسية</strong><strong> </strong><strong>شديدة</strong>، وقد يؤثر بعضها على<strong> </strong>البشرة في صورة إكزيما أو طفح جلدي وكدمات، أو بقع حمراء في الذراعين والساقين. وإذا شعرت برد فعل تحسسي، توقف عن تناول<strong> كابيتان</strong><strong>&reg;</strong> واطلب مشورة عاجلة من الطبيب، وأخبره أنك تتناول هذا الدواء.</p><p dir="RTL"><strong>قلل</strong><strong> </strong><strong>من</strong><strong> </strong><strong>ممارسة</strong><strong> </strong><strong>الرياضة</strong><strong> </strong><strong>والأنشطة</strong><strong> </strong><strong>البدنية</strong><strong> </strong><strong>المكثفة</strong>. فقد يسبب كابيتان&reg; آلامًا<strong> </strong>في العضلات والمفاصل، خاصة لدى الأطفال والمراهقين الذين يمارسون أنشطة بدنية عنيفة.</p><p dir="RTL"><strong>تم</strong><strong> ربط كابيتان</strong><strong>&reg;</strong><strong> بمرض داء الأمعاء الالتهابي</strong>. وسوف يوقفك الطبيب عن تناول<strong> </strong><strong>كابيتان</strong><strong>&reg;</strong> إذا تعرضت لإسهال دموي شديد دون أن يكون لديك تاريخ سابق من<strong> </strong>الاضطرابات المعدية المعوية.</p><p dir="RTL"><strong>&bull;</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>يُسبب</strong><strong> </strong><strong>كابيتان</strong><strong>&reg;</strong><strong> </strong><strong>جفاف</strong><strong> </strong><strong>العينين،</strong><strong> </strong><strong>وعدم</strong><strong> </strong><strong>تحمل</strong><strong> </strong><strong>العدسات</strong><strong> </strong><strong>اللاصقة،</strong><strong> </strong><strong>ومشكلات</strong><strong> </strong><strong>بصرية</strong><strong> تتضمن انخفاض الرؤية الليلية</strong>. وقد تم الإبلاغ عن حالات جفاف في العين<strong> </strong>لم تتحسن بعد توقف العلاج. فأخبر طبيبك إذا كنت تشعر بأي من تلك الأعراض. وقد يطلب منك الطبيب استخدام مرهم مرطب للعين أو علاج بديل للدموع. وإذا كنت تستخدم العدسات اللاصقة وأُصبت بعدم تحمل العدسات اللاصقة، قد تُنصَح بارتداء النظارة خلال فترة العلاج، وقد يقوم طبيبك بإحالتك إلى أخصائي لطلب النصيحة إذا تعرضت لصعوبات في الرؤية، وقد يُطلب منك التوقف عن تناول<strong> كابيتان</strong>.<strong>&reg;</strong></p><p>&nbsp;</p><p dir="RTL"><strong>تم</strong><strong> </strong><strong>الإبلاغ</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>إصابات</strong><strong> </strong><strong>فرط</strong><strong> </strong><strong>ضغط</strong><strong> </strong><strong>الدم</strong><strong> </strong><strong>الحميد</strong><strong> </strong><strong>داخل</strong><strong> </strong><strong>الجمجمة</strong><strong> </strong><strong>عند</strong><strong> </strong><strong>استخدام</strong><strong> </strong><strong>كابيتان</strong><strong>&reg;</strong><strong>،</strong> وفي بعض الحالات التي تم استخدام<strong> كابيتان</strong><strong>&reg;</strong> فيها مع التتراسيكلين<strong> </strong>)أحد أنواع المضادات الحيوية.( فتوقف عن تناول<strong> </strong><strong>كابيتان</strong><strong>&reg;</strong> واطلب النصيحة الطبية العاجلة من طبيبك إذا شعرت بأعراض، مثل: الصداع، والغثيان، والقيء، واضطرابات الرؤية. وقد يحيلك طبيبك إلى أخصائي ليتحقق من وجود تورم في القرص البصري في العين )وذمة حليمة العصب البصري.(</p><p dir="RTL"><strong>قد</strong><strong> </strong><strong>يسبب</strong><strong> </strong><strong>كابيتان</strong><strong>&reg;</strong><strong> </strong><strong>ارتفاعًا</strong><strong> </strong><strong>في</strong><strong> </strong><strong>مستويات</strong><strong> </strong><strong>إنزيمات</strong><strong> </strong><strong>الكبد</strong>. وسوف يجري لك طبيبك<strong> </strong>اختبارات للدم قبل وأثناء وبعد العلاج<strong> </strong><strong>بكابيتان</strong><strong>&reg;</strong> للتحقق من تلك المستويات. فإذا ظلت تلك المستويات مرتفعة، فقد يقوم طبيبك بتقليل جرعتك من<strong> كابيتان</strong><strong>&reg;</strong> أو يوقفك عن استخدامه.</p><p dir="RTL"><strong>يزيد</strong><strong> </strong><strong>كابيتان</strong><strong>&reg;</strong><strong> </strong><strong>في</strong><strong> </strong><strong>العادة</strong><strong> </strong><strong>نسبة</strong><strong> </strong><strong>الدهون</strong><strong> </strong><strong>في</strong><strong> </strong><strong>الدم</strong>، مثل الكوليسترول أو الدهون<strong> </strong>الثلاثية. وسيقوم طبيبك بإجراء اختبارات لمعرفة مستويات تلك الدهون قبل وأثناء وبعد العلاج<strong> بكابيتان</strong>.<strong>&reg;</strong> ومن الأفضل ألا تتناول المشروبات الكحولية، أو أن تُقلل - على الأقل- من الكميات التي تتناولها في العادة خلال فترة العلاج. أخبر طبيبك إذا كنت تعاني بالفعل من ارتفاع مستوى الدهون في الدم أو من مرض السكري )ارتفاع سكر الدم(، أو كنت تعاني من زيادة الوزن أو كنت مدمنًا على الكحول. وقد تحتاج لإجراء اختبارات الدم بتكرار أكبر. فإذا ظلت مستويات دهون الدم لديك مرتفعة، فقد يقوم طبيبك بتقليل جرعتك من<strong> كابيتان</strong><strong>&reg;</strong><strong>،</strong> أو يوقفك عن استخدامه.</p><p dir="RTL"><strong>أخبر</strong><strong> طبيبك إذا كانت لديك أي مشاكل بالكلى</strong>. قد يبدأ الطبيب العلاج بجرعة منحفضة<strong> </strong>من<strong> كابيتان</strong><strong>&reg;</strong><strong>،</strong> ثم يزيد الجرعة إلى أقصى جرعة يمكنك تحملها.</p><p dir="RTL"><strong>قد</strong><strong> يُسبب كابيتان</strong><strong>&reg;</strong><strong> ارتفاع مستويات سكر الدم</strong>. ففي حالات نادرة يُصاب الأشخاص<strong> </strong>بمرض السكري. وقد يراقب طبيبك مستويات سكر الدم لديك خلال فترة العلاج، خاصة إذا كنت مصابًا بالفعل بمرض السكري، أو كنت تعاني من زيادة الوزن، أو كنت مدمنًا على الكحول.</p><p dir="RTL"><strong>من</strong><strong> المحتمل أن تُصاب بشرتك بالجفاف</strong>. استخدم مرهمًا أو كريمًا مرطبًا للبشرة،<strong> </strong>وبلسم الشفاه أثناء فترة العلاج؛ لتجنب تهيج البشرة، ويجب أن تتجنب استخدام منتجات تقشير الجلد والمنتجات المضادة لحب الشباب.</p><p dir="RTL"><strong>تجنب</strong><strong> كثرة التعرض لأشعة الشمس، ولا تستخدم المصباح الشمسي أو جهاز تسمير البشرة</strong>. فقد تصبح بشرتك أكثر حساسية لضوء الشمس. قبل أن تخرج في الشمس،<strong> </strong>استخدم مُنتجًا للحماية من الشمس ذا معامل حماية مرتفع )معامل حماية من الشمس    أو أكثر.(</p><p dir="RTL"><strong>لا</strong><strong> </strong><strong>تستخدم</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>علاجات</strong><strong> </strong><strong>تجميلية</strong><strong> </strong><strong>للبشرة</strong>. فقد يجعل<strong> </strong><strong>كابيتان</strong><strong>&reg;</strong> بشرتك أكثر هشاشة.<strong> </strong>ولا تستخدم أي شمع )لإزالة الشعر( أو سنفرة للجلد أو علاجات ليزرية )إزالة الجلد المتقرن أو الندبات( طوال فترة العلاج، أو لمدة   أشهر على الأقل بعد العلاج. فقد تسبب تلك العلاجات في حدوث ندبات، أو تهيج للجلد، أو في حالات نادرة، تسبب تغيرات في لون بشرتك.</p><p>&nbsp;</p><p>الأطفال والمراهقون:</p><p dir="RTL">لا يُنصَح باستخدام<strong> كابيتان</strong><strong>&reg;</strong> بالنسبة للأطفال الذين تقل أعمارهم عن    عامًا؛ وذلك لأنه من غير المعروف ما إذا كان آمنًا أو فعالًا بالنسبة لهذه الفئة العمرية.</p><p dir="RTL">ويجب عدم استخدام كابيتان&reg; في علاج حب الشباب في مرحلة ما قبل البلوغ أو لدى الأطفال الذين تقل أعمارهم عن    عامًا.</p><p>&nbsp;</p><p>الأدوية الأخرى وكابيتان:&reg;</p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أو قد تناولت مؤخرًا أي أدوية أخرى، بما في ذلك المنتجات العشبية والأدوية التي تُصرف دون وصفة طبية.</p><p>&nbsp;</p><p dir="RTL"><strong>&bull;</strong><strong> </strong><strong>لا</strong><strong> </strong><strong>تتناول</strong><strong> مكملات غذائية تحتوي على فيتامين أ، أو التتراسيكلين</strong> )نوع من أنواع<strong> </strong>المضادات الحيوية(، أو تستخدم أيًّا من علاجات البشرة الخاصة بحب الشباب خلال فترة علاجك<strong> بكابيتان</strong>.<strong>&reg;</strong> ولا مانع من استخدام المرطبات والمطريات )كريمات أو مستحضرات للبشرة تساعد على منع فقدان الماء، ولها تأثير مُنعّم للبشرة.(</p><p>&bull; تجنب استخدام مذيب الكراتين &ldquo;المقشرات العلاجية الموضعية المستخدمة لإزالة</p><p dir="RTL"><strong>الثآليل</strong>&rdquo;<strong> </strong><strong>أو</strong><strong> </strong><strong>المقشرات</strong><strong> </strong><strong>المضادة</strong><strong> </strong><strong>لحب</strong><strong> </strong><strong>الشباب</strong> أثناء استخدامك<strong> </strong><strong>لكابيتان</strong>.<strong>&reg;</strong></p><p><strong>&nbsp;</strong></p><p>الحمل والرضاعة الطبيعية والخصوبة:</p><p dir="RTL">إذا كنتِ حاملًا أو تقومين بالرضاعة الطبيعية، أو تعتقدين أنكِ حامل، أو تخططين لإنجاب طفل، يجب عليك سؤال طبيبك للحصول على المشورة قبل تناول هذا الدواء. للمزيد من المعلومات بخصوص منع الحمل والحمل والرضاعة الطبيعية، راجع القسم   &laquo;برنامج منع الحمل.&raquo;</p><p>&nbsp;</p><p>القيادة واستخدام الآلات:</p><p dir="RTL">قد لا ترى جيدًا في الليل خلال فترة علاجك. قد يحدث ذلك فجأة. وقد استمر ذلك في بعض الحالات النادرة، بعد التوقف عن العلاج. وقد تم الإبلاغ عن الشعور بالنعاس والخمول في حالات نادرة جدًّا. فإذا حدث ذلك لك، يجب ألا تمارس القيادة أو تشغيل الآلات.</p><p>&nbsp;</p><p>يحتوي كابيتان&reg; على السوربيتول وزيت فول الصويا.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>&bull;</strong><strong> زيت</strong><strong> فول الصويا</strong>: إذا كنت تعاني من حساسية من الفول السوداني أو فول الصويا،<strong> </strong>فلا تأخذ هذا المنتج الطبي.</p><p dir="RTL"><strong>&bull;</strong><strong> السوربيتول</strong>: السوربيتول هو مصدر للفركتوز. فإذا أخبرك الطبيبك أنك )أو طفلك(<strong> </strong>تعاني من عدم تحمل بعض أنواع السكريات أو إذا تم تشخيص إصابتك بعدم تحمل الفركتوز الوراثي، وهو مرض جيني نادر، لا يتمكن الشخص المصاب به من تكسير الفركتوز، فتحدث إلى طبيبك قبل أن تتناول أو تحصل )أنت أو طفلك( على هذا الدواء.</p><p dir="RTL"><strong>&bull;</strong><strong> </strong><strong>كابيتان</strong><strong>&reg;</strong><strong> </strong><strong>10</strong><strong> </strong><strong>ملغ</strong>:<strong> </strong>يحتوي على:</p><p dir="RTL">- ما يصل إلى   ملغ من السوربيتول في كل كبسولة لينة. - بونسو 4 آر، مما قد يُسبّب ردود فعل تحسسية.</p><p><strong>&bull; كابيتان&reg; 20 ملغ:</strong></p><p dir="RTL">يحتوي على:</p><p dir="RTL">- ما يصل إلى 7 ملغ من السوربيتول في كل كبسولة لينة.</p><p dir="RTL">- أصفر غروب الشمس إف سي إف، مما قد يُسبب ردود فعل تحسسية.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول هذا الدواء دائمًا طبقًا للإرشادات الدقيقة للطبيب. ويجب مراجعة طبيبك أو الصيدلي إذا لم تكن متأكدًا.</p><p dir="RTL">الجرعة المبدئية المعتادة هي 0.5&nbsp;ملغ لكل كلغ من وزن الجسم (0.5ملغ/ كلغ/ يوم) ولذلك، إذا كان وزنك 60&nbsp;كلغ، فسوف تبدأ جرعتك في المعتاد بمقدار  30 ملغ يوميًّا.</p><p>تناول الكبسولات مرة واحدة أو مرتين يوميًّا.</p><p dir="RTL">تناول الكبسولات على معدة ممتلئة. ابتلع الكبسولة كاملة مع أحد المشروبات، أو تناولها مع الطعام.</p><p dir="RTL">قد يقوم طبيبك، بعد أسابيع قليلة، بضبط جرعتك. ويعتمد ذلك على حالتك بعد تناول هذا الدواء. فبالنسبة لمعظم المرضى، سوف تتراوح الجرعة ما بين 0.5 و 1 ملغ/ كلغ/ يوم. فإذا كنت تعتقد أن كابيتان&reg; قوي جدًّا أو ضعيف جدًّا، فتحدث إلى طبيبك أو الصيدلي.</p><p dir="RTL">إذا كنت تعاني من مشكلات خطيرة في الكِلَى، فسوف تبدأ عادة بجرعة منخفضة (على سبيل المثال 10 ملغ يوميًّا)، ثم تزداد بعد ذلك إلى الجرعة القصوى التي يمكن لجسدك أن يتحملها. وإذا لم يكن جسدك قادرًا على تحمل الجرعة الموصى بها، فقد تُوصف لك جرعة أقل، مما يعني أنك سوف تُعالَج لفترة أطول وتصبح أكثر عرضة لعودة حب الشباب مرة أخرى.</p><p dir="RTL">غالبًا ما تستمر الدورة العلاجية لمدة 16 إلى 24 شهرًا. ويحتاج معظم المرضى إلى دورة علاجية واحدة فقط. وقد يستمر التحسن في بشرتك من حب الشباب لديك لمدة تصل إلى 8 أسابيع بعد انتهاء العلاج. ولن تبدأ - في العادة- دورة علاجية أخرى حتى انتهاء تلك الفترة.</p><p dir="RTL">ويجد بعض الأشخاص أن حب الشباب لديهم يصبح أسوأ خلال فترة الأسابيع الأولى من العلاج، ولكنه يتحسن في الغالب مع الاستمرار في تلقي العلاج.</p><p>&nbsp;</p><p><strong>إذا تناولت كابيتان&reg; أكثر مما ينبغي:</strong></p><p dir="RTL">إذا تناولت الكثير من الكبسولات، أو تناول شخص آخر دواءك عن طريق الخطأ، فاتصل على الفور بالطبيب أو الصيدلي أو بأقرب مستشفى.</p><p><strong>إذا نسيت تناول كابيتان:&reg;</strong></p><p dir="RTL">إذا نسيت تناول إحدى الجرعات، فتناولها في أقرب وقتٍ ممكن، ولكن إذا كان الوقت قد حان تقريبًا لتناول جرعتك التالية، فتخطَّ الجرعة المنسية واستمر في تناول جرعاتك كما كنت تفعل سابقًا، ولا تتناول جرعة مزدوجة (جرعتين في موعدين متقاربين).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يُسبب هذا الدواء بعض الآثار الجانبية، على الرغم من أن ذلك لا يحدث مع الجميع. وتتعلق بعض الآثار الجانبية المرتبطة باستخدام أيزوتريتينوين بالجرعة. وبشكل عام، يمكن عكس الآثار الجانبية بعد تخفيف الجرعة أو إيقاف العلاج، وعلى الرغم من ذلك، قد تستمر بعض الآثار الجانبية بعد إيقاف العلاج. وقد تكون بعض الآثار الجانبية خطيرة، ويجب أن تُبلِغ طبيبك بها على الفور.</p><p>&nbsp;</p><p>الآثار الجانبية التي تحتاج إلى عناية طبية عاجلة: المشكلات الجلدية:</p><p dir="RTL"><strong>بتكرار</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>معروف</strong> (فلا يمكن تقدير تكرار الحدوث من خلال البيانات المُتاحة)</p><p><strong>&nbsp;</strong></p><p dir="RTL">طفح جلدي خطير (الحمامى &ldquo;احمرار الجلد&rdquo; عديدة الأشكال، ومتلازمة ستيفنز جونسون، وتقشُّر الأنسجة المُتموّتة البَشرَوِية التسمّمي) والذي يُحتمل أن يكون مهددًا للحياة، ويتطلب عناية طبية عاجلة. وتبدأ الأعراض في البداية في صورة بقع دائرية تحتوي في منتصفها في العادة على بثور، وتظهر غالبًا في الذراعين واليدين أو الساقين والقدمين، وقد تتضمن الأشكال الحادة من الطفح الجلدي ظهور بثور</p><p dir="RTL">في الصدر والظهر. وقد تظهر كذلك بعض الأعراض الإضافية، مثل: التهابات في العينين (التهاب الملتحمة)، وتقرحات في الفم أو الحلق أو الأنف. وقد تتطور الأشكال الحادة من الطفح الجلدي إلى تقشر واسع الانتشار للجلد يمكن أن يكون مهددًا للحياة. وغالبًا ما يسبق الإصابة بتلك الأشكال الخطيرة من الطفح الجلدي الإصابة بالصداع والحمى وآلام الجسم (أعراض تشبه أعراض الإنفلونزا)</p><p>&nbsp;</p><p>إذا تعرضت لطفح جلدي شديد أو أي من تلك الأعراض الجلدية الخطيرة، فتوقف عن تناول كابيتان&reg; واتصل بطبيبك على الفور.</p><p><strong>&nbsp;</strong></p><p dir="RTL"><strong>المشكلات العقلية</strong><strong>:</strong></p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>نادرة</strong> (قد تصيب ما يصل إلى 1 من كل 1000&nbsp;شخص):</p><p dir="RTL">&bull; الاكتئاب أو الاضطرابات المرتبطه به. وتتضمن الأعراض الشعور بالحزن أو تقلب المزاج، والقلق، والشعور بعدم الراحة العاطفية.</p><p dir="RTL">&bull; يصبح الاكتئاب الذي تعاني منه أكثر سوءًا.</p><p dir="RTL">&bull; تصبح عنيفًا أو عدوانيًّا.</p><p>&nbsp;</p><p>آثار نادرة جدًّا (قد تصيب ما يصل إلى 1 من كل 10،000&nbsp;شخص):</p><p dir="RTL">&bull; انتاب بعض الأشخاص أفكارًا تتعلق بإصابة أنفسهم بالأذى أو بإنهاء حياتهم )أفكار انتحارية(، أو حاولوا إنهاء حياتهم (محاولات انتحار)، أو أنهوا حياتهم (قاموا بالانتحار)، وقد لا يبدو على هؤلاء الناس الإصابة بالاكتئاب.</p><p dir="RTL">&bull; سلوكيات غير معتادة.</p><p dir="RTL">&bull; علامات على الذهان: فقدان الاتصال بالواقع، مثل: سماع أصوات، أو رؤية أشياء غير موجودة.</p><p>&nbsp;</p><p dir="RTL"><strong>اتصل</strong><strong> بطبيبك على الفور إذا شعرت بعلامات على أي من هذه المشكلات العقلية</strong>.<strong> </strong>وقد يطلب منك طبيبك التوقف عن تناول<strong> كابيتان</strong>.<strong>&reg;</strong> وقد لا يكون ذلك كافيًا لإيقاف التأثيرات، وقد تحتاج إلى المزيد من المساعدة التي يمكن لطبيبك أن يُرتبها لك.</p><p>&nbsp;</p><p>ردود الفعل التحسسية:</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>نادرة</strong> (قد تصيب ما يصل إلى  1 من كل1000 شخص):</p><p dir="RTL">&bull; ردود فعل خطيرة حساسية مفرطة: صعوبات في التنفس أو البلع يتسبب فيها التورم المفاجئ للحلق والوجه والشفاه والفم. وكذلك، التورم المفاجئ لليدين والقدمين والكاحل.</p><p>&nbsp;</p><p>آثار نادرة جدًّا (قد تصيب ما يصل إلى 1من كل 10،000شخص):</p><p dir="RTL">&bull; ضيق مفاجئ في الصدر وضيق في التنفس وصفير، خاصة إذا كنت مصابًا بالربو.</p><p>&nbsp;</p><p>إذا كنت تعاني من ردود فعل خطيرة، فاحصل على مساعدة طبية عاجلة على الفور.</p><p dir="RTL">إذا تعرضت لأي ردود فعل تحسسية، فتوقف عن تناول كابيتان&reg; واتصل بطبيبك.</p><p>&nbsp;</p><p>العظام والعضلات:</p><p dir="RTL"><strong>بتكرار</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>معروف</strong> (فلا يمكن تقدير تكرار الحدوث من خلال البيانات المتاحة).</p><p><strong>&nbsp;</strong></p><p dir="RTL">&bull; ضعف في العضلات يُحتمل أن يكون مهددًا للحياة، وقد ترافقه صعوبات في تحريك اليدين والقدمين أو وجود مناطق مؤلمة ومتورمة بها كدمات في الجسم، أو بول داكن اللون أو قلة البول أو احتباسه، أو تشوش أو جفاف. وتشير تلك الأعراض إلى انحلال الربيدات، وهو انحلال في الأنسجة العضلية يمكن أن يؤدي إلى حدوث فشل كلوي. وقد يحدث ذلك إذا كنت تقوم بنشاط بدني مكثف خلال فترة علاجك بكابيتان.&reg;</p><p>&nbsp;</p><p>مشكلات في الكبد والكلى:</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>نادرة</strong><strong> </strong><strong>جدًّا</strong><strong> </strong><strong>(</strong><strong>قد</strong><strong> </strong><strong>تصيب</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>1</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> </strong><strong>10،000</strong><strong> </strong><strong>شخص</strong><strong>):</strong></p><p dir="RTL">&bull; اصفرار في البشرة أو العينين، وشعور بالتعب. وقد تكون تلك علامات على الإصابة بالتهاب الكبد.<strong> </strong><strong>توقف</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>تناول</strong><strong> </strong><strong>كابيتان</strong><strong>&reg;</strong><strong> </strong><strong>على</strong><strong> </strong><strong>الفور</strong><strong> </strong><strong>واتصل</strong><strong> بطبيبك</strong><strong>.</strong></p><p dir="RTL">&bull; صعوبات في التبول (خروج البول) وتورم وانتفاخ الجفون، وشعور بالتعب المفرط. وقد تكون تلك علامات على التهاب الكلى.<strong> </strong><strong>توقف عن تناول كابيتان</strong><strong>&reg;</strong><strong> على</strong> <strong>الفور</strong><strong> واتصل بطبيبك</strong><strong>.</strong></p><p><strong>&nbsp;</strong></p><p>مشكلات في الجهاز العصبي:</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>نادرة</strong><strong> </strong><strong>جدًّا</strong><strong> </strong><strong>(</strong><strong>قد</strong><strong> </strong><strong>تصيب</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>1</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> </strong><strong>10،000</strong><strong>شخص</strong><strong>):</strong></p><p dir="RTL">صداع مستمر مع شعور بالإعياء (غثيان) أو إصابة بالإعياء (تقيؤ)، وتغير في الرؤية بما في ذلك تشوش في الرؤية. وقد تكون تلك علامات على الإصابة بفرط ضغط الدم الحميد داخل القحف، خاصة ما إذا كان يتم تناول كابيتان&reg; مع أحد المضادات الحيوية الذي يُدعَى تيتراسايكلن.<strong> توقف عن تناول كابيتان</strong><strong>&reg;</strong><strong> على الفور</strong> <strong>واتصل</strong><strong> </strong><strong>بطبيبك</strong><strong>.</strong></p><p><strong>&nbsp;</strong></p><p>مشكلات في الأمعاء والمعدة:</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>نادرة</strong><strong> </strong><strong>جدًّا</strong><strong> </strong><strong>(</strong><strong>قد</strong><strong> </strong><strong>تصيب</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong> </strong><strong>1</strong><strong> </strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> </strong><strong>10،000</strong><strong> </strong><strong>شخص</strong><strong>):</strong></p><p dir="RTL">&bull; ألم شديد في البطن، مصحوب بإسهال دموي شديد أو بدونه، أو شعور بالإعياء (الغثيان)، أو إصابة بالإعياء (تقيؤ). فقد تكون تلك علامات على الإصابة بأمراض خطيرة في الأمعاء.<strong> توقف</strong><strong> عن تناول كابيتان</strong><strong>&reg;</strong><strong> على الفور واتصل بطبيبك</strong><strong>.</strong></p><p>&nbsp;</p><p>اضطرابات في العينين:</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>نادرة</strong><strong> </strong><strong>جدًّا</strong><strong> </strong><strong>(</strong><strong>قد</strong><strong> </strong><strong>تصيب</strong><strong> </strong><strong>ما</strong><strong> </strong><strong>يصل</strong><strong> </strong><strong>إلى</strong><strong>&nbsp;1&nbsp;</strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> </strong><strong>10،000</strong><strong> </strong><strong>شخص</strong><strong>):</strong></p><p dir="RTL">&bull; تشوش الرؤية.</p><p>&nbsp;</p><p dir="RTL"><strong>إذا شعرت بتشوش في الرؤية، فتوقف عن تناول كابيتان</strong><strong>&reg;</strong><strong> على الفور واتصل</strong><strong> </strong><strong>بطبيبك</strong><strong>.</strong> وإذا تأثر بصرك بأي طريقة أخرى، فأبلغ طبيبك في أسرع وقت ممكن.</p><p><strong>&nbsp;</strong></p><p>آثار جانبية أخرى:</p><p dir="RTL"><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>شائعة</strong><strong> </strong><strong>جدًّا</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>كابيتان</strong><strong>&reg;</strong><strong> </strong><strong>(</strong><strong>قد</strong><strong> </strong><strong>تصيب</strong><strong> </strong><strong>أكثر</strong><strong> </strong><strong>من</strong><strong>&nbsp;1&nbsp;</strong><strong>من</strong><strong> </strong><strong>كل</strong><strong> </strong><strong>10&nbsp;</strong><strong>أشخاص</strong><strong>):</strong></p><p dir="RTL">&bull; جفاف في البشرة، خاصة في الشفتين والوجه والتهاب الجلد، وتشقق الشفاه والتهابها، وطفح جلدي، وحكة خفيفة وتقشير بسيط. استخدم كريمًا مرطبًا من بداية العلاج.</p><p dir="RTL">&bull; يصبح الجلد أكثر هشاشة واحمرارًا من المعتاد، خاصة الوجه.</p><p dir="RTL">&bull; ألم في الظهر أو ألم في العضلات أو ألم في المفاصل خاصة لدى الأطفال والمراهقين.</p><p>&nbsp;</p><p dir="RTL">ولتجنب تفاقم أي من مشكلات العظام أو العضلات، يجب تخفيف النشاط البدني المكثف خلال فترة العلاج<strong> بكابيتان</strong>.<strong>&reg;</strong></p><p dir="RTL">&bull; التهاب العينين (التهاب الملتحمة)&nbsp;ومنطقة الجفون وشعور بالجفاف والتهيج. اسأل الصيدلي عن القطرات المناسبة للعين. وإذا أُصبت بجفاف العين وكنت ترتدي العدسات اللاصقة، فقد تحتاج إلى ارتداء النظارة بدلًا منها.</p><p dir="RTL">&bull; ارتفاع في إنزيمات الكبد يظهر في اختبارات الدم.</p><p dir="RTL">&bull; تغيرات في مستويات الدهون في الدم (بما في ذلك البروتين الدهني المرتفع الكثافة والدهون الثلاثية).</p><p dir="RTL">&bull; كدمات أو نزيف أو تخثر الدم بسهولة أكبر- إذا تأثرت خلايا التخثر.</p><p dir="RTL">&bull; الأنيميا، والضعف، والدوار، وشحوب الجلد- إذا تأثرت خلايا الدم الحمراء.</p><p>&nbsp;</p><p>آثار جانبية شائعة مع كابيتان&reg; (قد تصيب ما يصل إلى 1 من كل 10 أشخاص):</p><p dir="RTL">&bull; صداع.</p><p dir="RTL">&bull; ارتفاع مستويات الكوليسترول في الدم.</p><p dir="RTL">&bull; بروتين أو دم في البول.</p><p dir="RTL">&bull; أكثر عُرضة للإصابة بالعدوى- إذا تأثرت خلايا الدم البيضاء.</p><p dir="RTL">&bull; يصبح الجزء الداخلي من الأنف جافًّا ومتقشرًا؛ مما يسبب نزيفًا خفيفًا في الأنف.</p><p dir="RTL">&bull; التهاب الحلق أو الأنف.</p><p dir="RTL">&bull; ردود فعل تحسسية، مثل الطفح الجلدي والحكة. فإذا كنت تعاني من ردود فعل تحسسية، فتوقف عن تناول كابيتان&reg; واتصل بطبيبك.</p><p>&nbsp;</p><p>آثار جانبية نادرة مع كابيتان&reg; (قد تصيب ما يصل إلى 1 من كل 1000 شخص):</p><p dir="RTL">&bull; تساقط الشعر (الثعلبة)، ولكن ذلك في العادة أمر مؤقت. وسيعود شعرك إلى طبيعته بعد انتهاء العلاج.</p><p>&nbsp;</p><p>آثار جانبية نادرة جدًّا مع كابيتان&reg; (قد تصيب ما يصل إلى 1 من كل 10،000 شخص):</p><p dir="RTL">&bull; قد لا ترى جيدًا في الليل، وتُصاب بعمى ألوان وتصبح رؤية الألوان أكثر سوءًا.</p><p dir="RTL">&bull; قد تزداد الحساسية للضوء، وقد تجد أنك تحتاج لارتداء نظارات شمسية لحماية عينيك من الوهج الشديد لضوء الشمس.</p><p dir="RTL">&bull; تتضمن المشكلات البصرية الأخرى تشوش الرؤية وتشوه الرؤية ووجود سطح غائم على العين (عتامة القرنية أو إعتام عدسة العين).</p><p dir="RTL">&bull; العطش الشديد والحاجة المتكررة للتبول، وتُظهر اختبارات الدم ارتفاع في مستويات سكر الدم. وقد يكون ذلك علامات على الإصابة بسكر الدم.</p><p dir="RTL">&bull; يصبح حب الشباب أسوأ خلال الأسابيع الأولى من العلاج، ولكن تلك الأعراض تتحسن مع الوقت.</p><p dir="RTL">&bull; تلتهب البشرة وتتورم وتصبح أدكن من المعتاد، خاصة في الوجه.</p><p dir="RTL">&bull; فرط العرق أو الحكة.</p><p dir="RTL">&bull; التهاب المفاصل، واضطرابات العظام )تأخر النمو وزيادة النمو والتغيرات في كثافة العظام(، وقد تتوقف العظام النامية عن النمو.</p><p dir="RTL">&bull; ترسبات الكالسيوم في الأنسجة الرخوة والتهاب الأوتار ووجود مستويات مرتفعة من نواتج تكسير العضلات في الدم، إذا كنت تمارس الرياضة بقوة.</p><p dir="RTL">&bull; زيادة الحساسية للضوء.</p><p dir="RTL">&bull; التهابات بكتيرية في قاعدة الظفر، وتغيرات في الأظافر.</p><p dir="RTL">&bull; تورمات وتفريغ صديد.</p><p dir="RTL">&bull; ندبات سميكة بعد العمليات الجراحية.</p><p dir="RTL">&bull; زيادة شعر الجسم.</p><p dir="RTL">&bull; تشنجات، ونعاس، ودوار.</p><p dir="RTL">&bull; قد تصبح الغدد الليمفاوية متورمة.</p><p dir="RTL">&bull; جفاف الحلق وخشونة الصوت.</p><p dir="RTL">&bull; صعوبات في السمع.</p><p dir="RTL">&bull; الشعور بتوعك.</p><p dir="RTL">&bull; ارتفاع مستويات حمض اليوريك في الدم.</p><p dir="RTL">&bull; عدوى بكتيرية.</p><p dir="RTL">&bull; التهاب الأوعية الدموية (يصاحبها في بعض الأحيان كدمات وبقع حمراء).</p><p>&nbsp;</p><p>بتكرار غير معروفة (لا يمكن تقدير تكرار الحدوث من خلال البيانات المتاحة)</p><p dir="RTL">&bull; البول الداكن أو بلون الكولا.</p><p dir="RTL">&bull; مشاكل في حدوث الانتصاب أو في الاحتفاظ به.</p><p dir="RTL">&bull; انخفاض الرغبة الجنسية.</p><p dir="RTL">&bull; تورم الثدي لدى الرجال مع أو دون طراوة.</p><p dir="RTL">&bull; جفاف المهبل.</p><p dir="RTL">&bull; التهاب المفصل العجزي الحرقفي ، وهو نوع من آلام الظهر الالتهابية التي تسبب ألمًا في الأرداف أو أسفل الظهر.</p><p dir="RTL">&bull; التهاب مجرى البول.</p><p>&nbsp;</p><p>الإبلاغ عن الآثار الجانبية:</p><p dir="RTL">إذا تعرضت لأي من الآثار الجانبية، فتحدث إلى طبيبك أو الصيدلي أو الممرضة. ويشمل ذلك أي آثار جانبية محتملة غير مدرجة في هذه النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull; يُحفظ هذا الدواء بعيدًا عن متناول ومرأى الأطفال.</p><p dir="RTL">&bull; يجب عدم استخدام الدواء بعد تاريخ الانتهاء الموضح على العبوة بعد كلمة .EXP ويُشير تاريخ الانتهاء إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">&bull; لا تستخدم هذا الدواء إذا لاحظت أن العبوة تالفة أو تظهر عليها علامات العبث.</p><p dir="RTL">&bull; يُحفظ في درجة حرارة أقل من  0 درجة مئوية.</p><p dir="RTL">&bull; يُخزّن في العبوة الأصلية. واحتفظ بالشريط في العلبة الكرتونية الخارجية لحمايتها من الضوء.</p><p dir="RTL">&bull; يجب عدم التخلص من الأدوية عن طريق مياه الصرف أو ضمن النفايات المنزلية. واستشر الصيدلي حول كيفية التخلص من الأدوية التي لم تعد في حاجة إليها. فتساعد تلك الإجراءات على حماية البيئة.</p><p>&bull; قم بإعادة الكبسولات المتبقية إلى الصيدلي، ولا تحتفظ بها إلا إذا أخبرك طبيبك بذلك</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull; المادة الفعالة في كابيتان&reg; هي الأيزوتريتينوين.</p><p dir="RTL">&bull; المكونات الأخرى هي أسيتات التوكوفيرول ألفا الراسيمي، زيت نباتي مهدرج )من النوع الثاني(، زيت فول الصويا المهدرج، شمع نحل أصفر، زيت فول الصويا</p><p dir="RTL">المكرر، جيلاتين، جليسرول، سائل السوربيتول المجفف جزئيًّا، ثنائي أكسيد التيتانيوم (E-171)، أزرق باتنت في (E-131) و أحمر بونسو 4 آر (E-124) للكبسولة 10 ملغ، أصفر غروب الشمس إف سي إف (E-110) للكبسولة  20&nbsp;ملغ، ماء نقي.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يأتي كابيتان&reg; في صورة كبسولات لينة تحتوي إما على 10 ملغ أو  20 ملغ من الأيزوتريتينوين.</p><p dir="RTL">الكبسولات  10 ملغ هي كبسولات لينة ذات لون بنفسجي، بحجم 3 ، بيضاوية. طول الكبسولة حوالي 11.1 مليمتر وعرضها حوالي 6.8 مليمتر.</p><p dir="RTL">الكبسولات  20 ملغ هي كبسولات لينة ذات لون مائل للاصفرار إلى كريمي، بحجم 6 ، بيضاوية. طول الكبسولة حوالي 13.8 مليمتر وعرضها حوالي 1.8 مليمتر.</p><p dir="RTL">تتوفر الكبسولات اللينة  10 ملغ و  20 ملغ في عبوة تحتوي على  30 كبسولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة الشرق الألوسط للصناعات الدوائية المحدودة (أفالون فارما)</p><p>8146 شارع الملك محمد الخامس, السليمانية، الرياض</p><p>3904-12223 ٫ ص.ب،4180: الرياض، 11491</p><p>المملكة العربية السعودية</p><p>رقم الهاتف: 920010564</p><p>رقم الفاكس: ٤٠٠٠٢٢٥ )١١( +٩٦٦</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            آخر تاريخ مراجعة لهذه النشرة في: 2024/06
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capitan 10 mg soft capsules.
Capitan 20 mg soft capsules.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capitan 10 mg: each soft capsule contains 10 mg of isotretinoin.
Capitan 20 mg: each soft capsule contains 20 mg of isotretinoin.
Excipients with known effect:
Each 10 mg soft capsule contains:
-	about 147 mg of soya-bean oil [soya-bean oil refined, soya-bean oil hydrogenated and hydrogenated vegetable oil (soya-bean oil, type II)]
-	up to 7.2 mg of sorbitol and
-	less than 1 mg of ponceau red 4R (E-124).

Each 20 mg soft capsule contains:
-	about 294 mg of soya-bean oil [soya-bean oil refined, soya-bean oil hydrogenated and hydrogenated vegetable oil (soya-bean oil, type II)]
-	up to 10 mg of sorbitol and
-	less than 1 mg of sunset yellow FCF (E-110).

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capsule, soft.

Capitan 10 mg: violet, size 3, oval soft capsules. Capsule length is approximately 11.1 mm and width is approximately 6.8 mm.
Capitan 20 mg: off-white to cream, size 6, oval soft capsules. Capsule length is approximately
13.8 mm and width is approximately 8.1 mm.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Severe forms of acne (such as nodular or conglobate acne or acne at risk of permanent scarring) resistant to adequate courses of standard therapy with systemic antibacterials and topical therapy.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>Capitan should only be prescribed by or under the supervision of physicians with expertise in the use of systemic retinoids for the treatment of severe acne and a full understanding of the risks of isotretinoin therapy and monitoring requirements.</p><p>&nbsp;</p><p>The capsules should be taken with food once or twice daily.</p><p>&nbsp;</p><p><em>Paediatric Population</em></p><p>Capitan should not be used for the treatment of prepubertal acne and is not recommended in children less than 12 years of age due to a lack of data on efficacy and safety.</p><p><em>Adults including adolescents and the elderly:</em></p><p>Isotretinoin therapy should be started at a dose of 0.5 mg/kg daily. The therapeutic response to isotretinoin and some of the adverse effects are dose-related and vary between patients. This necessitates individual dosage adjustment during therapy. For most patients, the dose ranges from 0.5-1.0 mg/kg per day.</p><p>Long-term remission and relapse rates are more closely related to the total dose administered than to either duration of treatment or daily dose. It has been shown that no substantial additional benefit is to be expected beyond a cumulative treatment dose of 120-150 mg/kg. The duration of treatment will depend on the individual daily dose. A treatment course of 16- 24 weeks is normally sufficient to achieve remission.</p><p>In the majority of patients, complete clearing of the acne is obtained with a single treatment course. In the event of a definite relapse a further course of isotretinoin therapy may be considered using the same daily dose and cumulative treatment dose. As further improvement of the acne can be observed up to 8 weeks after discontinuation of treatment, a further course of treatment should not be considered until at least this period has elapsed.</p><p><em>Patients with renal impairment</em></p><p>In patients with severe renal insufficiency treatment should be started at a lower dose (e.g. 10 mg/day). The dose should then be increased up to 1 mg/kg/day or until the patient is receiving the maximum tolerated dose (see section 4.4).</p><p><em>Patients with intolerance</em></p><p>In patients who show severe intolerance to the recommended dose, treatment may be continued at a lower dose with the consequences of a longer therapy duration and a higher risk of relapse. In order to achieve the maximum possible efficacy in these patients the dose should normally be continued at the highest tolerated dose.</p><p>&nbsp;</p><p><u>Method of administration</u> Oral use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capitan is contraindicated in women who are pregnant or breastfeeding (see section 4.6). Capitan is contraindicated in women of childbearing potential unless all of the conditions of the Pregnancy Prevention Programme are met (see section 4.4).
Capitan is also contraindicated in patients with hypersensitivity to isotretinoin or to any of the excipients listed in section 6.1. Capitan contains soya-bean oil refined, hydrogenated vegetable oil and hydrogenated soya-bean oil. Therefore, Capitan is contraindicated in patients allergic to peanut or soya
Capitan is also contraindicated in patients
•	With hepatic insufficiency
•	With excessively elevated blood lipid values
•	With hypervitaminosis A
•	Receiving concomitant treatment with tetracyclines (see section 4.5)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Teratogenic effects</strong></p><p>Capitan is a powerful human teratogen inducing a high frequency of severe and life threatening birth defects.</p><p><strong>Capitan is strictly contraindicated in:</strong></p><p>-&nbsp; Pregnant women</p><p>-&nbsp; Women of childbearing potential unless all of the conditions of the Pregnancy Prevention Programme are met</p><p>&nbsp;</p><p><strong>Pregnancy Prevention Programme</strong></p><p>This medicinal product is TERATOGENIC</p><p>&nbsp;</p><p>Capitan is contraindicated in women of childbearing potential unless all of the following conditions of the Pregnancy Prevention Programme are met:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; She has severe acne (such as nodular or conglobate acne or acne at risk of permanent scarring) resistant to adequate courses of standard therapy with systemic antibacterials and topical therapy (see section 4.1).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The potential for pregnancy must be assessed for all female patients</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; She understands the teratogenic risk.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; She understands the need for rigorous follow-up, on a monthly basis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; She understands and accepts the need for effective contraception, without interruption, 1 month before starting treatment, throughout the entire duration of treatment and 1 month after the end of treatment. At least one highly effective method of contraception (i.e. a user-independent form) or two complementary user-dependent forms of contraception should be used.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Individual circumstances should be evaluated in each case, when choosing the contraception method, involving the patient in the discussion, to guarantee her engagement and compliance with the chosen measures.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Even if she has amenorrhea she must follow all of the advice on effective contraception.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; She is informed and understands the potential consequences of pregnancy and the need to rapidly consult if there is a risk of pregnancy or if she might be pregnant.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; She understands the need and accepts to undergo pregnancy testing before, ideally monthly during treatment and 1 month after stopping treatment.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; She has acknowledged that she has understood the hazards and necessary precautions associated with the use of isotretinoin.</p><p>These conditions also concern women who are not currently sexually active unless the prescriber considers that there are compelling reasons to indicate that there is no risk of pregnancy.</p><p>&nbsp;</p><p>The prescriber must ensure that:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The patient complies with the conditions for pregnancy prevention as listed above, including confirmation that she has an adequate level of understanding.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The patient has acknowledged the aforementioned conditions.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The patient understands that she must consistently and correctly use one highly effective method of effective contraception (i.e. a user-independent form) or two complementary user-dependent forms of contraception, for at least 1 month prior to starting treatment and is continuing to use effective contraception throughout the treatment period and for at least 1 month after cessation of treatment.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Negative pregnancy test results have been obtained before, during and 1 month after the end of treatment. The dates and results of pregnancy tests should be documented.</p><p>If pregnancy occurs in a woman treated with isotretinoin, treatment must be stopped and the patient should be referred to a physician specialised or experienced in teratology for evaluation and advice.</p><p>&nbsp;</p><p>If pregnancy occurs after stopping treatment there remains a risk of severe and serious malformation of the fetus. This risk persists until the product has been completely eliminated, which is within one month following the end of treatment.</p><p>&nbsp;</p><p>Contraception</p><p>Female patients must be provided with comprehensive information on pregnancy prevention and should be referred for contraceptive advice if they are not using effective contraception. If the prescribing physician is not in a position to provide such information the patient should be referred to the relevant healthcare professional.</p><p>As a minimum requirement, female patients of childbearing potential must use at least one highly effective method of contraception (i.e. a user-independent form), or two complementary user-dependent forms of contraception. Contraception should be used for at least 1 month prior to starting treatment, throughout treatment and continue for at least 1 month after stopping treatment with Capitan, even in patients with amenorrhea.</p><p>&nbsp;</p><p>Individual circumstances should be evaluated in each case, when choosing the contraception method involving the patient in the discussion, to guarantee her engagement and compliance with the chosen measures.</p><p>Pregnancy testing</p><p>According to local practice, medically supervised pregnancy tests with a minimum sensitivity of 25mIU/mL are recommended to be performed, as follows.</p><p>&nbsp;</p><p><em><u>Prior to starting therapy:</u></em></p><p>At least one month after the patient has started using contraception, and shortly (preferably a few days) prior to the first prescription, the patient should undergo a medically supervised pregnancy test. This test should ensure the patient is not pregnant when she starts treatment with isotretinoin.</p><p><em><u>Follow-up visits</u></em></p><p>Follow-up visits should be arranged at regular intervals, ideally monthly. The need for repeated medically supervised pregnancy tests every month should be determined according to local practice including consideration of the patient&#39;s sexual activity and recent menstrual history (abnormal menses, missed periods or amenorrhea) and method of contraception. Where indicated, follow-up pregnancy tests should be performed on the day of the prescribing visit or in the 3 days prior to the visit to the prescriber.</p><p>&nbsp;</p><p><em><u>End of treatment</u></em></p><p>One month after stopping treatment, women should undergo a final pregnancy test.</p><p>&nbsp;</p><p>Prescribing and dispensing restrictions</p><p>For women of childbearing potential, the prescription duration of Capitan should ideally be limited to 30 days in order to support regular follow up, including pregnancy testing and monitoring. Ideally, pregnancy testing, issuing a prescription and dispensing of isotretinoin should occur on the same day. &lt;Dispensing of isotretinoin should occur within a maximum of 7 days of the prescription (the implementation of this element lies to the National Competent Authorities).˃</p><p>&nbsp;</p><p>This monthly follow-up will allow ensuring that regular pregnancy testing and monitoring is performed and that the patient is not pregnant before receiving the next cycle of medication</p><p>Male patients:</p><p>The available data suggest that the level of maternal exposure from the semen of the patients receiving isotretinoin, is not of a sufficient magnitude to be associated with the teratogenic effects of isotretinoin. Male patients should be reminded that they must not share their medication with anyone, particularly not females.</p><p><strong>Additional precautions</strong></p><p>Patients should be instructed never to give this medicinal product to another person, and to return any unused capsules to their pharmacist at the end of treatment.</p><p>&nbsp;</p><p>Patients should not donate blood during therapy and for 1 month following discontinuation of Capitan because of the potential risk to the foetus of a pregnant transfusion recipient.</p><p>Educational material</p><p>In order to assist prescribers, pharmacists and patients in avoiding foetal exposure to Capitan the Marketing Authorisation Holder will provide educational material to reinforce the warnings about the teratogenicity of Capitan, to provide advice on contraception before therapy is started and to provide guidance on the need for pregnancy testing.</p><p>&nbsp;</p><p>Full patient information about the teratogenic risk and the strict pregnancy prevention measures as specified in the Pregnancy Prevention Programme should be given by the physician to all patients, both male and female.</p><p>&nbsp;</p><p><strong>Psychiatric disorders</strong></p><p>Depression, depression aggravated, anxiety, aggressive tendencies, mood alterations, psychotic symptoms, and very rarely, suicidal ideation, suicide attempts and suicide have been reported in patients treated with isotretinoin (see section 4.8). Particular care needs to be taken in patients with a history of depression and all patients should be monitored for signs of depression and referred for appropriate treatment if necessary. However, discontinuation of isotretinoin may be insufficient to alleviate symptoms and therefore further psychiatric or psychological evaluation may be necessary.</p><p>&nbsp;</p><p>Awareness by family or friends may be useful to detect mental health deterioration.</p><p>Skin and subcutaneous tissues disorders</p><p>Acute exacerbation of acne is occasionally seen during the initial period but this subsides with continued treatment, usually within 7 - 10 days, and usually does not require dose adjustment.</p><p>Exposure to intense sunlight or to UV rays should be avoided. Where necessary a sun- protection product with a high protection factor of at least SPF 15 should be used.</p><p>Aggressive chemical dermabrasion and cutaneous laser treatment should be avoided in patients on isotretinoin for a period of 5-6 months after the end of the treatment because of the risk of hypertrophic scarring in atypical areas and more rarely post inflammatory hyper or</p><p>&nbsp;</p><p>hypopigmentation in treated areas. Wax depilation should be avoided in patients on isotretinoin for at least a period of 6 months after treatment because of the risk of epidermal stripping.</p><p>&nbsp;</p><p>Concurrent administration of isotretinoin with topical keratolytic or exfoliative anti-acne agents should be avoided as local irritation may increase (see section 4.5).</p><p>&nbsp;</p><p>Patients should be advised to use a skin moisturizing ointment or cream and a lip balm from the start of treatment as Capitan is likely to cause dryness of the skin and lips.</p><p>There have been post-marketing reports of severe skin reactions (e.g. erythema multiforme (EM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)) associated with isotretinoin use. As these events may be difficult to distinguish from other skin reactions that may occur (see section 4.8), patients should be advised of the signs and symptoms and monitored closely for severe skin reactions. If a severe skin reaction is suspected, isotretinoin treatment should be discontinued.</p><p>&nbsp;</p><p><strong>Allergic reactions</strong></p><p>Anaphylactic reactions have been rarely reported, in some cases after previous topical exposure to retinoids. Allergic cutaneous reactions are reported infrequently. Serious cases of allergic vasculitis, often with purpura (bruises and red patches) of the extremities and extracutaneous involvement have been reported. Severe allergic reactions necessitate interruption of therapy and careful monitoring.</p><p>&nbsp;</p><p><strong>Capitan 10 mg: Ponceau 4R. </strong>May cause allergic reactions.</p><p><strong>Capitan 20 mg: Sunset yellow FCF</strong>. May cause allergic reactions.</p><p>Eye disorders</p><p>Dry eyes, corneal opacities, decreased night vision and keratitis usually resolve after discontinuation of therapy. Cases of dry eyes not resolving after discontinuation of therapy have been reported. Dry eyes can be helped by the application of a lubricating eye ointment or by the application of tear replacement therapy. Intolerance to contact lenses may occur which may necessitate the patient to wear glasses during treatment.</p><p>Decreased night vision has also been reported and the onset in some patients was sudden (see section 4.7). Patients experiencing visual difficulties should be referred for an expert ophthalmological opinion. Withdrawal of Capitan may be necessary.</p><p>&nbsp;</p><p><strong>Musculo-skeletal and connective tissue disorders</strong></p><p>Myalgia, arthralgia and increased serum creatine phosphokinase values have been reported in patients receiving isotretinoin, particularly in those undertaking vigorous physical activity (see section 4.8). In some cases, this may progress to potentially life threatening rhabdomyolysis.</p><p>Bone changes including premature epiphyseal closure, hyperostosis, and calcification of tendons and ligaments have occurred after several years of administration at very high doses for treating disorders of keratinisation. The dose levels, duration of treatment and total cumulative dose in these patients generally far exceeded those recommended for the treatment of acne.</p><p>&nbsp;</p><p>Sacroiliitis has been reported in patients exposed to isotretinoin. To differentiate sacroiliitis from other causes of back pain, in patients with clinical signs of sacroiliitis, further evaluation may be needed including imaging modalities such as MRI. In cases reported post-marketing, sacroiliitis improved after discontinuation of Capitan and appropriate treatment.</p><p>&nbsp;</p><p><strong>Benign intracranial hypertension</strong></p><p>Cases of benign intracranial hypertension have been reported, some of which involved concomitant use of tetracyclines (see section 4.3 and section 4.5). Signs and symptoms of benign intracranial hypertension include headache, nausea and vomiting, visual disturbances and papilloedema. Patients who develop benign intracranial hypertension should discontinue Capitan immediately.</p><p><strong>Hepatobiliary disorders</strong></p><p>Liver enzymes should be checked before treatment, 1 month after the start of treatment, and subsequently at 3 monthly intervals unless more frequent monitoring is clinically indicated. Transient and reversible increases in liver transaminases have been reported. In many cases these changes have been within the normal range and values have returned to baseline levels during treatment. However, in the event of persistent clinically relevant elevation of transaminase levels, reduction of the dose or discontinuation of treatment should be considered.</p><p>&nbsp;</p><p><strong>Renal insufficiency</strong></p><p>Renal insufficiency and renal failure do not affect the pharmacokinetics of isotretinoin. Therefore, Capitan can be given to patients with renal insufficiency. However, it is recommended that patients are started on a low dose and titrated up to the maximum tolerated dose (see section 4.2).</p><p><strong>Lipid Metabolism</strong></p><p>Serum lipids (fasting values) should be checked before treatment, 1 month after the start of treatment, and subsequently at 3 monthly intervals unless more frequent monitoring is clinically indicated. Elevated serum lipid values usually return to normal on reduction of the dose or discontinuation of treatment and may also respond to dietary measures.</p><p>&nbsp;</p><p>Isotretinoin has been associated with an increase in plasma triglyceride levels. Capitan should be discontinued if hypertriglyceridaemia cannot be controlled at an acceptable level or if symptoms of pancreatitis occur (see section 4.8). Levels in excess of 800mg/dL or 9mmol/L are sometimes associated with acute pancreatitis, which may be fatal.</p><p>&nbsp;</p><p><strong>Gastrointestinal disorders</strong></p><p>Isotretinoin has been associated with inflammatory bowel disease (including regional ileitis) in patients without a prior history of intestinal disorders. Patients experiencing severe (haemorrhagic) diarrhoea should discontinue Capitan immediately.</p><p>&nbsp;</p><p><strong>Fructose intolerance</strong></p><p>Capitan contains sorbitol. Patients with hereditary fructose intolerance (HFI) should not take this medicinal product.</p><p>&nbsp;</p><p><strong>High Risk Patients</strong></p><p>In patients with diabetes, obesity, alcoholism or a lipid metabolism disorder undergoing treatment with Capitan, more frequent checks of serum values for lipids and/or blood glucose may be necessary. Elevated fasting blood sugars have been reported, and new cases of diabetes have been diagnosed during isotretinoin therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients should not take vitamin A as concurrent medication due to the risk of developing hypervitaminosis A.</p><p>Cases of benign intracranial hypertension (pseudotumor cerebri) have been reported with concomitant use of isotretinoin and tetracyclines. Therefore, concomitant treatment with tetracyclines must be avoided (see section 4.3 and section 4.4).</p><p>Concurrent administration of isotretinoin with topical keratolytic or exfoliative anti-acne agents should be avoided as local irritation may increase (see section 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy:</u></p><p><!--[if gte vml 1]><o:wrapblock><v:shapetype
  id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
  <v:stroke joinstyle="miter"/>
  <v:path gradientshapeok="t" o:connecttype="rect"/>
 </v:shapetype><v:shape id="Textbox_x0020_4" o:spid="_x0000_s1026" type="#_x0000_t202"
  style='position:absolute;margin-left:84.6pt;margin-top:13pt;width:426.25pt;
  height:63.75pt;z-index:-15728128;visibility:visible;mso-wrap-style:square;
  mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;
  mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
  mso-position-horizontal-relative:page;mso-position-vertical:absolute;
  mso-position-vertical-relative:text;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" filled="f" strokeweight=".48pt">
  <v:path arrowok="t"/>
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal style='margin-top:0in;margin-right:5.0pt;margin-bottom:
     0in;margin-left:5.15pt;margin-bottom:.0001pt;text-align:justify'><b
     style='mso-bidi-font-weight:normal'>Pregnancy is an <u>absolute</u>
     contraindication to treatment with Capitan (see section 4.3). Women of
     childbearing potential have to use effective contraception during and up
     to one month after treatment. If pregnancy does occur in spite of these
     precautions during treatment with Capitan or in the month following, there
     is a great risk of very severe<span style='letter-spacing:2.0pt'> </span>and
     serious malformation of the foetus.<o:p></o:p></b></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td></tr></tbody></table><table border="1" cellspacing="1" cellpadding="1" style="width:653px"><tbody><tr><td style="width:650px"><strong>Pregnancy is an <u>absolute</u> contraindication to treatment with Capitan (see section 4.3). Women of childbearing potential have to use effective contraception during and up to one month after treatment. If pregnancy does occur in spite of these precautions during treatment with Capitan or in the month following, there is a great risk of very severe and serious malformation of the foetus.</strong></td></tr></tbody></table><p>The foetal malformations associated with exposure to isotretinoin include central nervous system abnormalities (hydrocephalus, cerebellar malformation/abnormalities, microcephaly), facial dysmorphia, cleft palate, external ear abnormalities (absence of external ear, small or absent external auditory canals), eye abnormalities (microphthalmia), cardiovascular abnormalities (conotruncal malformations such as tetralogy of Fallot, transposition of great vessels, septal defects), thymus gland abnormality and parathyroid gland abnormalities. There is also an increased incidence of spontaneous abortion.</p><p>If pregnancy occurs in a woman treated with Capitan, treatment must be stopped and the patient should be referred to a physician specialized or experienced in teratology for evaluation and advice.</p><p><u>Breast-feeding</u>:</p><p>Isotretinoin is highly lipophilic, therefore the passage of isotretinoin into human milk is very likely. Due to the potential for adverse effects in the child exposed via mothers&#39; milk, the use of isotretinoin is contraindicated in nursing mothers (see section 4.3).</p><p>&nbsp;</p><p><u>Fertility:</u></p><p>Isotretinoin, in therapeutic dosages, does not affect the number, motility and morphology of sperm and does not jeopardise the formation and development of the embryo on the part of the male taking isotretinoin.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Capitan could potentially have an influence on the ability to drive and use machines.</p><p>A number of cases of decreased night vision have occurred during isotretinoin therapy and in rare instances have persisted after therapy (see section 4.4 and section 4.8). Because the onset in some patients was sudden, patients should be advised of this potential problem and warned to be cautious when driving or operating machines.</p><p>Drowsiness, dizziness and visual disturbances have been reported very rarely. Patients should be warned that if they experience these effects, they should not drive, operate machinery or take part in any other activities where the symptoms could put either themselves or others at risk.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Some of the side effects associated with the use of isotretinoin are dose-related. The side effects are generally reversible after altering the dose or discontinuation of treatment; however some may persist after treatment has stopped. The following symptoms are the most commonly reported undesirable effects with isotretinoin: dryness of the skin, dryness of the mucosae e.g. of the lips (cheilitis), the nasal mucosa (epistaxis), and the eyes (conjunctivitis).</p><p><u>Tabulated list of adverse reactions</u></p><p>The incidence of the adverse reactions calculated from pooled clinical trial data involving 824 patients and from post-marketing data are presented in the table below. The adverse reactions are listed below by MedDRA system organ class (SOC) and categories of frequency.</p><p>Frequency categories are defined as Very common (&ge;1/10), Common (&ge;1/100 to &lt;1/10), Uncommon (&ge;1/1,000 to &lt;1/100), Rare (&ge;1/10,000 to &lt;1/1,000), Very rare (&lt;1/10,000) and not known (cannot be estimated from the available data). Within each frequency grouping and SOC, adverse reactions are presented in order of decreasing seriousness.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p style="text-align:center"><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p style="text-align:center"><strong>Very common</strong></p></td><td style="vertical-align:top"><p style="text-align:center"><strong>Common</strong></p></td><td style="vertical-align:top"><p style="text-align:center"><strong>Rare</strong></p></td><td style="vertical-align:top"><p style="text-align:center"><strong>Very rare</strong></p></td><td style="vertical-align:top"><p style="text-align:center"><strong>Not </strong><strong>known*</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Infections </strong><strong>and</strong></p><p><strong>infestations</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Gram&nbsp;positive (mucocutaneous) bacterial infection</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Blood</strong><strong>&nbsp;and lymphatic system disorders</strong></p></td><td style="vertical-align:top"><p>Thrombocytopenia, anaemia, thrombocytosis, red&nbsp;blood&nbsp;cell sedimentation rate increased</p></td><td style="vertical-align:top"><p>Neutropenia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Lymphadenopathy</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Anaphylactic reactions, hypersensitivity, allergic&nbsp;skin reaction</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Metabolism </strong><strong>and </strong><strong>nutrition disorders</strong></p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Diabetes mellitus, hyperuricaemia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><strong>Psychiatric disorders</strong></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Depression, depression aggravated, anxiety, aggressive tendencies, mood&nbsp;<span style="background-color:transparent">alterations</span></p></td><td style="vertical-align:top">Suicide, suicide attempt, suicidal ideation, psychotic disorder, abnormal behaviour</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><strong>Nervous system disorders</strong></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">Headache</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Benign intracranial hypertension, convulsions,&nbsp;<span style="background-color:transparent">drowsiness, dizziness</span></p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><strong>Eye disorders</strong></td><td style="vertical-align:top">Blepharitis, conjunctivitis, dry eye, eye&nbsp;irritation</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">Papilloedema (as sign of benign intracranial hypertension), cataract, colour blindness (colour vision deficiencies), contact lens intolerance, corneal opacity, decreased night vision, keratitis, photophobia, visual disturbances,<br />blurred vision</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Ear&nbsp;</strong><strong>and&nbsp;</strong><strong style="background-color:transparent">labyrinth disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">Hearing impaired</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><strong>Vascular disorders</strong></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Vasculitis&nbsp;(for example Wegener&#39;s granulomatosis,&nbsp;<span style="background-color:transparent">allergic vasculitis)</span></p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><strong>Respiratory, thoracic&nbsp; and mediastinal disorders</strong></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">Nasopharyngitis, epistaxis, nasal dryness</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Bronchospasm (particularly&nbsp; &nbsp;in patients with asthma),&nbsp;<span style="background-color:transparent">hoarseness</span></p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><strong>Gastrointestinal disorders</strong></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Inflammatory bowel&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disease, colitis,&nbsp;ileitis, pancreatitis, gastrointestinal haemorrhage, haemorrhagic diarrhoea, nausea, dry&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; throat (see&nbsp;<span style="background-color:transparent">section 4.4)</span></p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><strong>Hepatobiliary disorders</strong></td><td style="vertical-align:top">Transaminase increased (see section 4.4)</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">Hepatitis</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><strong>Skin and subcutaneous tissues disorders</strong></td><td style="vertical-align:top"><p>Pruritus, rash erythematous, dermatitis, cheilitis,&nbsp;dry skin, localised exfoliation, skin fragility (risk&nbsp;of f<span style="background-color:transparent">rictional trauma)</span></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">Alopecia</td><td style="vertical-align:top"><p>Acne fulminans, acne aggravated (acne flare), erythema (facial), exanthema,&nbsp;hair disorders, hirsutism,&nbsp;nail dystrophy, paronychia, photosensitivity reaction, pyogenic&nbsp;<span style="background-color:transparent">granuloma, skin hyperpigmentation&nbsp;</span>sweating increased</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><strong>Musculo- skeletal and connective tissue disorders</strong></td><td style="vertical-align:top">Arthralgia, myalgia, back pain (particularly in children and adolescent patients)</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top">Arthritis, calcinosis (calcification&nbsp; of ligaments and tendons), epiphyses premature&nbsp; fusion, exostosis, (hyperostosis), reduced&nbsp;bone&nbsp;density, tendonitis</td><td style="vertical-align:top">Rhabdomyolysis Sacroiliitis</td></tr><tr><td style="vertical-align:top"><strong>Renal and urinary disorders</strong></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">Glomerulonephritis</td><td style="vertical-align:top">Urethritis</td></tr><tr><td style="vertical-align:top"><p><strong>Reproductive system</strong><strong>&nbsp;and breast&nbsp;</strong><strong style="background-color:transparent">disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Sexual dysfunction including erectile dysfunction and decreased libido, gynaecomastia,&nbsp;<span style="background-color:transparent">vulvovaginal dryness</span></p></td></tr><tr><td style="vertical-align:top"><p><strong>General disorders</strong><strong>&nbsp;and administration&nbsp;</strong><strong style="background-color:transparent">site conditions&nbsp;</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Granulation tissue (increased formation&nbsp;&nbsp;&nbsp;&nbsp; of),</p>malaise</td><td style="vertical-align:top">&nbsp;</td></tr></tbody></table><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>System</strong><strong>&nbsp;&nbsp;&nbsp;&nbsp; Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Very </strong><strong>common</strong></p></td><td style="vertical-align:top"><p><strong>Common</strong></p></td><td style="vertical-align:top"><p><strong>Rare</strong></p></td><td style="vertical-align:top"><p><strong>Very rare</strong></p></td><td style="vertical-align:top"><p><strong>Not known*</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Investigations</strong></p></td><td style="vertical-align:top"><p>Blood triglycerides increased, high&nbsp;&nbsp;&nbsp;&nbsp; density lipoprotein decreased</p></td><td style="vertical-align:top"><p>Blood cholesterol increased, blood glucose increased, haematuria,</p><p>proteinuria</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Blood&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; creatine phosphokinase increased</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>*cannot be estimated from the available data</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions.</p><p>To Report any side effects:</p><p><strong><em>Saudi Arabia:</em></strong></p><p>The National Pharmacovigilance Centre (NPC)</p><p>o&nbsp; SFDA call center: 19999</p><p>o&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>o&nbsp; Website: https://ade.sfda.gov.sa</p><p><strong>Other GCC States:</strong></p><p><strong>- </strong>Please contact the relevant competent authority</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Isotretinoin is a derivative of vitamin A. Although the acute toxicity of isotretinoin is low, signs of hypervitaminosis A could appear in cases of accidental overdose. Manifestations of acute vitamin A toxicity include severe headache, nausea or vomiting, drowsiness, irritability and pruritus. Signs and symptoms of accidental or deliberate overdosage with isotretinoin would probably be similar. These symptoms would be expected to be reversible and to subside without the need for treatment.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Anti-acne preparations, Retinoids for treatment of acne. ATC code: D10BA01</p><p>Mechanism of action</p><p>Isotretinoin is a stereoisomer of all-trans retinoic acid (tretinoin). The exact mechanism of action of isotretinoin has not yet been elucidated in detail, but it has been established that the improvement observed in the clinical picture of severe acne is associated with suppression of sebaceous gland activity and a histologically demonstrated reduction in the size of the sebaceous glands. Furthermore, a dermal anti-inflammatory effect of isotretinoin has been established.</p><p>&nbsp;</p><p><strong>Clinical efficacy </strong><strong>and safety</strong></p><p>Hypercornification of the epithelial lining of the pilosebaceous unit leads to shedding of corneocytes into the duct and blockage by keratin and excess sebum. This is followed by formation of a comedone and, eventually, inflammatory lesions. Isotretinoin inhibits proliferation of sebocytes and appears to act in acne by re-setting the orderly program of differentiation. Sebum is a major substrate for the growth of Propionibacterium acnes so that reduced sebum production inhibits bacterial colonisation of the duct.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong></p><p>The absorption of isotretinoin from the gastro-intestinal tract is variable and dose-linear over the therapeutic range. The absolute bioavailability of isotretinoin has not been determined, since the compound is not available as an intravenous preparation for human use, but extrapolation from dog studies would suggest a fairly low and variable systemic bioavailability. When isotretinoin is taken with food, the bioavailability is doubled relative to fasting conditions.</p><p>&nbsp;</p><p><strong>Distribution</strong></p><p>Isotretinoin is extensively bound to plasma proteins, mainly albumin (99.9 %). The volume of distribution of isotretinoin in man has not been determined since isotretinoin is not available as an intravenous preparation for human use. In humans little information is available on the distribution of isotretinoin into tissue. Concentrations of isotretinoin in the epidermis are only half of those in serum. Plasma concentrations of isotretinoin are about 1.7 times those of whole blood due to poor penetration of isotretinoin into red blood cells.</p><p><strong>Biotransformation</strong></p><p>After oral administration of isotretinoin, three major metabolites have been identified in plasma: 4-oxo-isotretinoin, tretinoin, (all-trans retinoic acid), and 4-oxo-tretinoin. These metabolites have shown biological activity in several in vitro tests. 4-oxo-isotretinoin has been shown in a clinical study to be a significant contributor to the activity of isotretinoin (reduction in sebum excretion rate despite no effect on plasma levels of isotretinoin and tretinoin). Other minor metabolites includes glucuronide conjugates. The major metabolite is 4-oxo-isotretinoin with plasma concentrations at steady state that are 2.5 times higher than those of the parent compound.</p><p>Isotretinoin and tretinoin (all-trans retinoic acid) are reversibly metabolised (interconverted), and the metabolism of tretinoin is therefore linked with that of isotretinoin. It has been estimated that 20-30 % of an isotretinoin dose is metabolised by isomerisation.</p><p>Enterohepatic circulation may play a significant role in the pharmacokinetics of isotretinoin in man. In vitro metabolism studies have demonstrated that several CYP enzymes are involved in the metabolism of isotretinoin to 4-oxo-isotretinoin and tretinoin. No single isoform appears to have a predominant role. Isotretinoin and its metabolites do not significantly affect CYP activity.</p><p><strong>Elimination</strong></p><p>After oral administration of radiolabelled isotretinoin approximately equal fractions of the dose were recovered in urine and faeces. Following oral administration of isotretinoin, the terminal elimination half-life of unchanged drug in patients with acne has a mean value of 19 hours. The terminal elimination half-life of 4-oxo-isotretinoin is longer, with a mean value of 29 hours.</p><p>Isotretinoin is a physiological retinoid and endogenous retinoid concentrations are reached within approximately two weeks following the end of isotretinoin therapy.</p><p>&nbsp;</p><p><strong>Hepatic impairment</strong></p><p>Since isotretinoin is contraindicated in patients with hepatic impairment, limited information on the kinetics of isotretinoin is available in this patient population.</p><p><strong>Renal impairment</strong></p><p>Renal failure does not significantly reduce the plasma clearance of isotretinoin or 4-oxo- isotretinoin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1.1&nbsp; Acute toxicity</p><p>The acute oral toxicity of isotretinoin was determined in various animal species. LD50 is approximately 2000 mg/kg in rabbits, approximately 3000 mg/kg in mice, and over 4000 mg/kg in rats.</p><p>&nbsp;</p><p>Chronic toxicity</p><p>A long-term study in rats over 2 years (isotretinoin dosage 2, 8 and 32 mg/kg/d) produced evidence of partial hair loss and elevated plasma triglycerides in the higher dose groups. The side effect spectrum of isotretinoin in the rodent thus closely resembles that of vitamin A, but does not include the massive tissue and organ calcifications observed with vitamin A in the rat. The liver cell changes observed with vitamin A did not occur with isotretinoin.</p><p>All observed side effects of hypervitaminosis A syndrome were spontaneously reversible after withdrawal of isotretinoin. Even experimental animals in a poor general state had largely recovered within 1&ndash;2 weeks.</p><p>&nbsp;</p><p>Teratogenicity</p><p>Like other vitamin A derivatives, isotretinoin has been shown in animal experiments to be teratogenic and embryotoxic.</p><p>&nbsp;</p><p>Due to the teratogenic potential of isotretinoin there are therapeutic consequences for the administration to women of a childbearing age (see section 4.3, section 4.4, and section 4.6).</p><p>&nbsp;</p><p>Mutagenicity</p><p>Isotretinoin has not been shown to be mutagenic in <em>in vitro </em>or <em>in vivo </em>animal tests.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Capsule filling:</u></p><p>all-rac -&alpha;- tocopheryl acetate</p><p>hydrogenated vegetable oil (Soya bean,type II) soya-bean oil hydrogenated</p><p>beeswax yellow soya-bean oil refined</p><p><u>Capsule shell:</u></p><p>gelatin glycerol</p><p>sorbitol liquid partially dehydrated titanium dioxide (E-171)</p><p>water purified</p><p><em>10mg: </em>patent blue V (E-131) ponceau red 4R (E-124).</p><p><em>20mg: </em>sunset yellow FCF (E-110).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Capitan 10 mg soft capsules: 2 years. 
Capitan 20 mg soft capsules: 2 years.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C</p><p>Store in the original package and keep blister in the outer carton in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blisters of orange PVC/TE/PVdC<strong>/</strong>aluminium foil.</p><p><em>10 mg soft capsules</em></p><p>Pack sizes: 30 capsules</p><p><em>20 mg soft capsules</em></p><p>Pack sizes: 30 capsules</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Return any unused Capitan capsules to the Pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Middle East Pharmaceutical Industries Company (Avalon-Pharma)
8146 King Muhammad V, Sulimaniyah, P.O. Box 4180, Riyadh 12223 - 3904 Kingdom of Saudi Arabia

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                07/2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>